ciprofloxacin has been researched along with ro13-9904 in 438 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (2.28) | 18.7374 |
| 1990's | 52 (11.87) | 18.2507 |
| 2000's | 120 (27.40) | 29.6817 |
| 2010's | 162 (36.99) | 24.3611 |
| 2020's | 94 (21.46) | 2.80 |
| Authors | Studies |
|---|---|
| Ayyagari, A; Gulati, S; Kumar, L; Marwaha, RK; Prakash, D; Singhi, P; Singhi, S; Walia, BN | 1 |
| Allard, S; Auger, F; Bisson, C; Daviau, N; Drapeau, C; LeBel, M; Paradis, D; Vallée, F | 1 |
| Bradshaw, MW; Harris, RL; Williams, TW; Zighelboim, J | 1 |
| Broide, E; Douer, D; Lieberman, Y; Rosen, N; Rubinstein, E; Segev, S; Shaked, N; Yellin, A | 1 |
| Keller, N; Overbeek, BP; Raponi, G; Rozenberg-Arska, M; Torensma, R; Verhoef, J | 1 |
| López, P; Rosell, F; Salas, R; Vinuesa, T | 1 |
| Yoshikawa, TT | 1 |
| Gruninger, RP; Guay, DR; Hirata-Dulas, CA; Peterson, PK; Stein, DJ | 1 |
| Brady, W; Bryan, JP; Hira, SK; Krieg, R; Luo, N; Mpoko, G; Mwale, C; Reichart, C; Siwiwaliondo, E; Waters, C | 1 |
| Altwegg, M; Hohl, P; Lüthy-Hottenstein, J; Zollinger-Iten, J | 1 |
| Hayran, M; Kocagöz, T; Sener, B; Ustaçelebi, S | 1 |
| Aulicino, TM; Berkowitz, LB; duBouchet, L; Gombert, ME | 1 |
| Daschner, F; Kropec, A | 1 |
| Kujath, P | 1 |
| Gaunt, PN | 1 |
| Ariza, J; Bosch, J; Cisnal, MC; Liñares, J; López de Goicoechea, MJ; Martin, R | 1 |
| Bayer, AS; Blomquist, IK; Norman, DC | 1 |
| Brunham, RC; Le Saux, NM; Plummer, FA; Ronald, AR; Slaney, LA | 1 |
| Gruninger, R; Guay, DR; Gustilo, RB; Peterson, PK; Tsukayama, DT; Wicklund, B | 1 |
| Wall, RA | 1 |
| Lettau, LA | 1 |
| Mazzei, T; Nicoletti, P; Novelli, A; Periti, P; Reali, EF | 1 |
| Cavallo, JD; Chevalier, B; Meyran, M | 1 |
| Leung, M | 1 |
| Grasmug, E; Hammer, HF; Hoefler, G; Reisinger, EC; Stauber, RE; Trauner, M | 1 |
| Gopinath, R; Kain, KC; Keystone, JS | 1 |
| Cuevas, LE; Hart, CA; Kazembe, P; Mughogho, GK; Tillotson, GS | 1 |
| Barthold, SW; Malawista, SE; Persing, DH | 1 |
| Hyams, KC; Mahroos, GA; Mapes, T; Rowe, B; Threlfall, EJ; Wallace, MR; Yousif, AA | 1 |
| Bolan, GA; Echols, R; Haag, JJ; Hook, EW; Jones, RB; Martin, DH; Mroczkowski, TF; Neumann, TM | 1 |
| Gorwitz, RJ; Knapp, JS; Moran, JS; Nakashima, AK | 1 |
| Ismaeel, NA | 1 |
| Bertasso, A; Georgopapadakou, NH | 1 |
| Kanchanapongkul, J | 1 |
| Blondeau, JM; Yaschuk, Y | 1 |
| Coughlan, EP; Franklin, RA | 1 |
| Birthistle, K; Eltringham, IJ; Hutchinson, NA; Lee, PY; Martin, MJ | 1 |
| Abeck, D; Ballard, RC | 1 |
| Chen, YS; Cheng, DL; Liu, YC; Wang, JH; Wann, SR; Yen, MY | 1 |
| Biedenbach, DJ; Jones, RN | 1 |
| Durrani, AB; Rab, SM | 1 |
| Arredondo, JL; Diaz, V; Gaitan, H; Maradiegue, E; Oyarzún, E; Paz, R; Reynal, JL; Stamm, W; Zambrano, D | 1 |
| Hanif, M; Islam, M; Ruhulamin, M; Saha, S; Saha, SK | 1 |
| Cormio, L; La Forgia, D; La Forgia, P; Ruutu, M; Siitonen, A | 1 |
| Atkins, BL; Gottlieb, T | 1 |
| Dessens, M; van de Laar, MJ; van Duynhoven, YT; van Klingeren, B; van Santen, M | 1 |
| Amyes, SG; Cakir, N; Gülay, Z; Mehr, MA; Yüce, A; Yulug, N | 1 |
| Abo Rahmy, E | 1 |
| Gonzalez-Torres, C; Jiménez-Valera, M; Moreno, E; Ruiz-Bravo, A | 1 |
| Cavallo, JD; Fabre, R; Martet, G; Nicolas, P | 1 |
| Barkay, A; Block, C; Keller, N; Leitner, L; Leventhal, A; Shehab, S | 1 |
| Barbabietola, G; Bucaneve, G; Cavicchi, F; Del Favero, A; Gentile, G; Iori, AP; Landonio, G; Martino, P; Menichetti, F; Micozzi, A; Minotti, V | 1 |
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Bianco, G; Capone, A; Cassone, M; Tarasi, A; Tarasi, D; Venditti, M | 1 |
| Cometta, A; De Bock, R; Gaya, H; Kern, WV; Langenaeken, J; Paesmans, M | 1 |
| Cannon, JG; Johnston, DM | 1 |
| Caldelari, I; Entenza, JM; Glauser, MP; Moreillon, P | 1 |
| Campos, MC; Dantas, LS; Ginani, VC; Petrilli, AS; Seber, A; Tanaka, C | 1 |
| Guoming, L; Qun, C; Shengchun, W | 1 |
| Bala, M; Kumar, J; Misra, RS; Ray, K | 1 |
| Donovan, KD; Gage, JW; Shapiro, MA | 1 |
| Hsueh, PR; Hung, CC; Jang, TN; Lu, PL; Luh, KT; Teng, LJ | 1 |
| Au, T; Breen, D; Reiss-Levy, E; Schonell, M | 1 |
| Arreaza, L; de la Fuente, L; Fernández, S; Vázquez, JA | 1 |
| Barfod, S | 1 |
| Debiao, W; Jinlan, Y; Minchang, W; Ping, L; Shi, F; Wenling, C; Xibao, Z | 1 |
| de Louvois, J; Price, EH; Workman, MR | 1 |
| Dagan, R; Janco, J; Leibovitz, E; Piglansky, L; Press, J; Reinhart, H; Yagupsky, P; Yaniv, I | 1 |
| Arora, H; Eckert, S; Johann-Liang, R; Noel, GJ; Purswani, M | 1 |
| Dragsted, UB; Pedersen, P | 1 |
| Dillon, JA; Li, H; Prabhakar, P; Ruben, M; Sealy, J | 1 |
| Basak, M; Bhattacharya, SK; Datta, S; De, A; Dutta, P; Mitra, U; Roy, K; Saha, MR | 1 |
| Aggelis, P; Dalamaga, A; Ferti, A; Garzonis, P; Kanavaki, S; Kapralos, C; Karambela, S; Makarona, M; Roussos, A; Stambori, M | 1 |
| Brown, A; Camara, B; Castor, D; Furlonge, C; Jolly, PE; Prabhakar, P; Rao, A; Weiss, H | 1 |
| Bhattacharya, SK; Chatterjee, MK; De, A; Dutta, P; Dutta, S; Mitra, U | 1 |
| Abraham, G; Arthur, P; Gouthaman, S; Manjunath, S; Mathew, M; Sekhar, U | 1 |
| Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
| Alcalá, B; Arreaza, L; Salcedo, C; Vázquez, JA | 1 |
| Khatib, R; Maollod, L; Naqvi, A; Sharma, M | 1 |
| Paganini, H; Zubizarreta, P | 1 |
| Banky, JP; Ostergaard, L; Spelman, D | 1 |
| Bózsik, BP | 1 |
| Barkham, T; Bellamy, R | 1 |
| Caulin, C; Fiszbin, M; Gravisse, J; Hanau-Berçot, B; Raskine, L; Rottman, M; Sanson-Le Pors, MJ | 1 |
| Bosso, JA; Enzweiler, KA; Friedrich, LV; Hoban, D; Wagner, D; White, RL | 1 |
| Hiltunen-Back, E; Reunala, T | 1 |
| Ellbogen, MH; Gentry-Nielsen, MJ; Olsen, KM; Preheim, LC | 1 |
| Asimakopoulos, C; Bassaris, H; Harlaftis, N; Karravias, D; Kolaras, P; Nikolaidis, P; Skoutelis, A; Starakis, I | 1 |
| Castellano, G; Morillasa, JD; Pérez Carreras, M; Solís, JA; Tomás, ME | 1 |
| Ain, Q; Barney, N; Iqbal, M; Kiani, Q; Mehdi, B; Patel, IK; Rabbani, KZ; Shah, SH; Zaidi, G | 1 |
| Casimir, L; Debbag, R; Fraquelli, L; Gómez, S; Iturres, AS; Latella, A; Paganini, H; Ruvinsky, S; Zubizarreta, P | 1 |
| Balkhy, HH; Memish, ZA; Rich, M | 1 |
| Beaman, BL; Holodniy, M; Johnson, F; Lopez, FA; Novosad, DM | 1 |
| Alvarez-Vijande, R; Bargalló, X; Bru, C; Buñesch, L; Horcajada, JP; Martínez, JA; Mensa, J; Moreno-Martínez, A; Vilana, R | 1 |
| Bala, M; Kumari, S; Ray, K | 1 |
| Alawattegama, AB; Corkill, JE; Hart, CA; Komolafe, AJ; Mortimore, A; Neal, TJ | 1 |
| Akinci, E; Aksaray, S; Balaban, N; Bodur, H; Colpan, A; Erbay, A; Yetener, V | 1 |
| Dillon, JA; Li, H; Llanes, R; Llop, A; Ramirez-Arcos, S; Ruben, M; Sosa, J | 1 |
| Alli, OO; Bakare, RA; Fayemiwo, SA; Kehinde, AO; Oni, AA; Umar, US | 1 |
| Cao, WL; Fei, S; Luo, Q; Zhang, XB | 1 |
| Cao, WL; Wu, XZ; Yang, LG; Zheng, HP | 1 |
| Danielsen, AG; Friis-Møller, A; Wildt, S | 1 |
| Cellesi, C; Donati, E; Migliorini, L; Sansoni, S; Zanelli, G | 1 |
| Ammann, RA | 1 |
| Chia, JH; Chiu, CH; Chu, C; Lee, YS; Lin, TY; Ou, JT; Su, LH; Wu, TL | 1 |
| Celikbaş, A; Dokuzoğuz, B; Ergönül, O; Imre, A | 1 |
| Arnold, DM; Christjanson, L; Smaill, F; Walker, I; Warkentin, TE | 1 |
| Ambrosch, A; Dietlein, M; Kullmann, KH; Lehnert, H; Lobmann, R; Seewald, M; Zink, K | 1 |
| Harish, BN; Madhulika, U; Parija, SC | 1 |
| Bergmann, JF; Jarrin, I; Mahé, I; Mai, T; Mouly, S; Sellier, P | 1 |
| Ho, SW; Hsieh, SM; Hsueh, PR; Hung, CC; Sun, HY; Teng, LJ; Tseng, SP | 1 |
| Chuang, YC; Ko, WC; Lee, HC; Lee, NY; Wang, LR; Yan, JJ; Yu, WL | 1 |
| Deotale, V; Mendiratta, DK; Narang, P | 1 |
| Asonganyi, ED; Njunda, AL; Nkemngu, NJ | 1 |
| Carpenter, V; Flanagan, K; Killingley, B; Pasvol, G | 1 |
| Meltzer, MI; Roy, K; Wang, SA | 1 |
| Bala, M; Gupta, SM; Ray, K | 1 |
| Kenton, I; McKinnon, PS; Mohr, JF; Okhuysen, PC; Peymann, PJ; Septimus, E | 1 |
| Chaudhary, C; Das, AK; Hasan Chaudhary, FA; Hossain, A; Kansaker, P; Karki, N; Malla, S; Neilsen, G; Pandy, AR; Rahman, M; Ross, JL | 1 |
| Easow, JM; Mukhopadhyay, C; Prabhu, N; Wilson, G | 1 |
| Lev-El, A; Miron, D; Zuker, M | 1 |
| Arosey, A; Blanco, JR; Castilla, A; Ibarra, V; Morano, LE; Oteo, JA | 1 |
| Laber, DA; Morgan, JS | 1 |
| Chuang, YM; Hsueh, PR; Kuo, SH; Lee, LN; Teng, LJ; Wang, CY; Yang, PC | 1 |
| Alomary, IY; Kamha, AA; Khan, FY | 1 |
| Acar, B; Aysev, D; Ekim, M; Güriz, H; Kavaz, A; Ozçakar, ZB; Oztürk, B; Yalçinkaya, F; Yüksel, S | 1 |
| Gardner, P | 1 |
| Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M | 1 |
| Li, JT; Markus, P; Matesic, D; Park, M | 1 |
| Albaksami, O; Dimitrov, T; Kilani, AA; Shehab, EMR; Udo, EE | 1 |
| Catt, CJ; Males, JJ; Symes, RJ | 1 |
| Bouzat, P; Broux, C; Croizé, J; Jacquot, C; Pavese, P; Soriano, E; Stahl, JP | 1 |
| Chan, MR; Pirsch, JD | 1 |
| Bazet, C; Curbelo, A; Formento, C; Gerez, J; Larrañaga, E; Medina, J; Pontet, J | 1 |
| Akça, O; Orhan-Sungur, M | 1 |
| Baucheron, S; Bertrand, S; Cloeckaert, A; Collard, JM; Denis, O; Place, S; Rodriguez-Villalobos, H; Struelens, M; Vrints, M; Weill, FX | 1 |
| Bangtrakulnonth, A; Chatsuwan, T; Chongthaleong, A; Kulwichit, W; Pulsrikarn, C; Unhasuta, C | 1 |
| Erkin, G; Isik, SR; Kalyoncu, AF; Karakaya, G | 1 |
| Onche, II; Thanni, LO; Yinusa, W | 1 |
| Chiu, YL; Hsueh, PR; Hung, PH | 1 |
| Ollé-Goig, JE | 1 |
| Bassaris, H; Karatza, C; Siagris, D; Solomou, H; Starakis, I | 1 |
| Arias Miranda, IM; Cienfuegos Basanta, MC; Fonseca Aizpuru, EM; Nuño Mateo, FJ | 1 |
| Putcharoen, O; Suankratay, C | 1 |
| Furuya, R; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Onoye, Y; Saika, T; Tanaka, M; Tatewaki, M | 1 |
| Baqui, AH; El Arifeen, S; Nair, GB; Rahman, M; Rashid, H; Sack, DA; Shoma, S; Siddique, AK | 1 |
| Black, V; Lewis, DA; Magooa, P; Myers, M; Pillay, C; Radebe, F | 1 |
| Chen, HH; Chen, YC; Lin, CJ; Wu, CJ | 1 |
| Brunel, AS; Fraisse, T; Laporte, S; Lechiche, C; Sotto, A | 1 |
| Arslan, H; Ekinci, MN; Erdogan, A; Erdogan, H; Hoscan, MB | 1 |
| Karthik, R | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Day, M; de Pinna, E; Jones, J; Lawrence, J; Threlfall, EJ | 1 |
| Hsu, PK; Hsu, WH | 1 |
| du Plessis, N; Lewis, DA; Mhlongo, S; Radebe, F; Scott, L; Sello, M; Slabbert, M; van Zijl, A; Wasserman, E | 1 |
| Kohler, BM; Türoff, A; Vollnberg, H | 1 |
| Biesiada, G; Czepiel, J; Garlicki, A; Mach, T; Salamon, D; Skwara, P; Sobczyk-Krupiarz, I | 1 |
| Akman, Y; Cam, K; Erol, A; Kayikci, A | 1 |
| Bercion, R; Cao, V; Fonkoua, MC; Ratsima, E; Richard, V; Talarmin, A; Van Tri, D | 1 |
| Gupta, A; Gupta, BK; Kochar, DK; Purohit, VP; Saharan, G; Sharma, BP | 1 |
| Antoun, S; Chachaty, E; Farhat, H; Nitenberg, G; Zahar, JR | 1 |
| Cohen, R; Gendrel, D | 1 |
| Beck, N; Chanteret, C; Duvillard, C; Folia, M; Gazzano, E; Lecomte, H; Mahy, S; Piroth, L; Romanet, P | 1 |
| Giannakakis, T; Hatzitolios, A; Kollaras, P; Kordosis, T; Metallidis, S; Nikolaidis, J; Nikolaidis, P; Seitanidis, B | 1 |
| Abdi-Ali, A; Falsafi, T; Nikname, V; Rahmani-Badi, A | 1 |
| Bormann, AM; Boulware, DR | 1 |
| Forsyth, H; Graham, SM; Mankhambo, LA; Molyneux, EM; Molyneux, ME; Phiri, A; Walsh, AL; Wilson, LK | 1 |
| Jongwutiwes, U; Malathum, K; Sungkanuparph, S | 1 |
| Aubert, T; Bourhaba, K; Crétel, E; Heim, M; Rovery, C; Singeorzan, S | 1 |
| Carlos, C; Chang, HH; Chiu, CH; Chongthaleong, A; Hsueh, PR; Jung, SI; Kim, SW; Kumarasinghe, G; Lee, HY; Liu, JW; Park, KH; Perera, J; So, T; Song, JH; Su, LH; Tan, BH; Tsai, MH | 1 |
| Anne, G; Bernard, F; Chapuis, M; Chevalier, J; Fraisse, B; Gaschet, A; Gorret, J; Jolivet-Gougeon, A; Julie, C; Julie, G; Madeleine, C; Philippe, V; Violas, P | 1 |
| Ralandison, S; Randriamboavonjy, R; Rapelanoro Rabenja, F | 1 |
| Avril, MF; Dupin, N; Farhi, D; Gerhardt, P; Hotz, C; Morand, P; Poupet, H; Poyart, C; Sednaoui, P | 1 |
| Furukawa, K; Futatsuyama, M; Kaneshiro, Y; Komatsu, Y; Nishizaki, Y; Taki, F; Tamagaki, K; Tsugawa, Y | 1 |
| Barrett, L; Bessong, PO; Guerrant, RL; Igumbor, EO; Obi, CL; Samie, A | 1 |
| Klein, M; Pfister, HW | 1 |
| Appelbaum, PC; Ednie, LM; Lin, G; Pankuch, GA | 1 |
| Maurya, P; Nath, G | 1 |
| Black, RE; Munos, M; Traa, BS; Walker, CL | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Gaborieau, V; Marchou, B; Weill, FX | 1 |
| Majtan, J; Majtan, V; Majtanova, L | 1 |
| Deb, M; Gaind, R; Mohanty, S; Paglietti, B; Paul, P; Rubino, S | 1 |
| Yagnik, VD | 1 |
| Arranz, DM; Díaz, RM; Ruiz-Bravo, E; Valverde, R | 1 |
| Contini, C; De Giorgi, A; Fabbian, F; Fratti, D; Pala, M | 1 |
| Alış, EE; Cengiz, M; Ekici, S; Turan, G | 1 |
| Dineen, PF; Dolan, AM; Harty, JA | 1 |
| Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK | 1 |
| Dupouët, L; Faucon, AL; Pruna, A; Zamfir, O | 1 |
| Fraser, A; Gafter-Gvili, A; Leibovici, L; Paul, M; Zalmanovici Trestioreanu, A | 2 |
| Chen, XS; Dai, XQ; Pearline, RV; Unemo, M; Xiang, Z; Yin, YP; Yuan, LF | 1 |
| Agarwal, A; Belokar, WK; Hirachan, S; Karmacharya, A; Praveen, CR | 1 |
| Preet, S; Rishi, P; Singh, AP | 1 |
| Bansal, N; Chander, J; Kaistha, N | 1 |
| Bergin, CJ; Crowley, B; Loh, JK; O'Connell, K; O'Shea, D | 1 |
| Bordon, JM; Karlowsky, JA; Master, RN; Sanchez, GV | 1 |
| Chayakulkeeree, M; Siriboon, S; Taweemongkongsup, T; Thamlikitkul, V; Tiengrim, S | 1 |
| Bak, N; Holds, JM; Papanicolas, LE | 1 |
| Barthel, M; Endt, K; Hardt, WD; Käppeli, R; Kremer, M; Maier, L; Misselwitz, B | 1 |
| Berro Castiglioni, M; Gerez, J; Medina Presentado, JC; Paciel López, D | 1 |
| Biçer, M; Durdu, B; Durdu, Y; Güleç, N; Islim, F | 1 |
| Maguiña, C; Seas, C; Villaverde, H | 1 |
| Fadeyi, A; Olajide, TG; Segun-Busari, S | 1 |
| Choi, CH; Kim, DM; Lim, SC; Neupane, GP; Shin, SH; Yun, NR | 1 |
| Ballesteros, AM; Benzaken, AS; Borthagaray, G; Carbajal, JL; Carvallo, ME; Cruz, OM; Dillon, JA; Galarza, P; Hernandez, AL; Payares, D; Starnino, S | 1 |
| Amornchai, P; An, KP; Baker, S; Carter, MJ; Chanpheaktra, N; Chheng, K; Day, NP; Duy, PT; Emary, K; Kumar, V; Moore, CE; Nga, TV; Parry, CM; Sona, S; Stoesser, NE; Wijedoru, L; Wuthiekanun, V | 1 |
| Fernando, S; Gottlieb, T; Molland, JG | 1 |
| Christison, F; Corcoran, DS; Dancer, SJ; Farmer, D; Kirkpatrick, P; Robertson, C | 1 |
| Akinsal, EC; Demirtas, A; Ekmekcioglu, O; Gulmez, I; Kaya, EG; Sofikerim, M; Tombul, ST; Yildirim, YE | 1 |
| Chen, S; Liu, JH; Wong, MH; Zeng, L | 1 |
| Angeles, J; Jiang, JJ; Zhang, S | 1 |
| Hall, RL; Partridge, R; Venkatraman, N; Wiselka, M | 1 |
| Bouillot, P; Brière, M; Lechiche, C; Olivier, V; Sotto, A | 1 |
| Bolan, G; del Rio, C; Hall, G; Holmes, KH; Holmes, KK; Hook, EW; Kirkcaldy, RD; Papp, J; Soge, O; Weinstock, HS; Zaidi, A | 1 |
| Barzilay, EJ; Chiller, TM; Griffin, PM; Hoekstra, RM; Joyce, K; Krueger, A; Medalla, F; Rickert, R; Stuart, A; Whichard, JM | 1 |
| Egesie, JO; Kashibu, E; Nwadioha, SI; Nwokedi, EO; Onwuezube, I | 1 |
| Haque, N; Hoque, SM; Hossain, MA; Kabir, MR; Paul, SK; Rahman, A; Sultana, S | 1 |
| Koedijk, FD; Stirbu-Wagner, I; van Bergen, JE; van den Broek, I | 1 |
| Anagaw, B; Biadgelgene, F; Endris, M; Geleshe, T; Getie, B; Gezachew, M; Mulu, A; Taddese, B; Unakal, C | 1 |
| Bao, Y; Cai, Y; Chai, T; Gao, J; Li, X; Ma, R; Zhao, X; Zhou, Y | 1 |
| Dorin, M; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M | 1 |
| Chen, YX; Hu, GZ; Liu, JH; Pan, YS; Wu, H; Yuan, L | 1 |
| Archuleta, S; Fisher, D; Gandhi, M; Lye, D; Molton, J; Phillips, R; Tan, TT; Yoong, J | 1 |
| Batra, P; Dutta, R; Dwivedi, M; Saxena, S | 1 |
| de Melo Oliveira, MD; Hauser, P; Kovari, H; Läuchli, S; Meyer, J; Weber, R; Zbinden, R | 1 |
| Dillon, JA; Horsman, GB; Levett, PN; Thakur, SD | 1 |
| Endimiani, A; Furrer, H; Guilarte, YN; Hauser, C; Hirzberger, L; Lupo, A; Selvini, S; Tinguely, R | 1 |
| Benham, A; Blakey, G; Davis, J; Puzio, C; Slobodov, G | 1 |
| Biao, K; Chan, EW; Chen, S; Wong, MH; Yan, M | 1 |
| Chauhan, B; Gupta, M; Singh, H; Singh, S | 1 |
| Furubayashi, K; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Tsai, HY | 1 |
| Frigo, N; Khairullin, R; Kubanov, A; Kubanova, A; Semina, V; Solomka, V; Unemo, M; Vorobyev, D | 1 |
| Chen, X; Dai, XQ; Gan, Q; Huang, YJ; Li, W; Liang, M; Wei, JP; Yin, Y; Yu, RX; Zhu, BY | 1 |
| Balmat, RP; Saum, LM | 1 |
| Brunner, A; Karpati, S; Marschalko, M; Mihalik, N; Nemes-Nikodem, E; Ostorhazi, E | 1 |
| Latif, Z; Sarwar, A | 1 |
| Božić, DD; Ćirković, I; Ivković, B; Milenković, M | 1 |
| Alibay, A; Antoun, S; Borget, I; Chachaty, E; Di Palma, M; Gachot, B; Merad, M | 1 |
| Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Unemo, M; Van de Laar, M | 1 |
| Cheng, CW; Li, LH; Li, SY; Su, CY; Yen, MY | 1 |
| Bi, C; Cao, WL; Li, P; Li, XD; Liang, JY; Liang, YH; Yang, RD; Ye, XD; Zhang, XB; Zhong, DQ | 1 |
| Chen, Y; Gu, WM; Hu, WZ; Jin, YL; Wu, L; Yang, Y | 1 |
| Chevli, KK; Danforth, T; Duff, M; Luong, B; Suraf, M; Visnjevac, O | 1 |
| Unwala, DJ | 1 |
| Enriquez, RP; Lahra, MM | 4 |
| Lahra, MM | 1 |
| Bala, M; Bhargava, A; Ramesh, V; Singh, V | 1 |
| Krishnamurthy, S; Mandal, I; Parija, SC; Sangeetha, AV | 1 |
| Cassidy, L; Curry, A; Knowles, SJ; McAnena, L | 1 |
| Nepomnyashchiy, VV; Shakalova, EA; Tamm, TI | 1 |
| Cole, M; Fredlund, H; Jacobsson, S; Ringlander, J; Unemo, M; Wiggins, C | 1 |
| Butichi, A; Lemnge, M; Lushino, P; Lusingu, J; Mahende, C; Mmbando, B; Ngasala, B; Premji, Z | 1 |
| Gupta, K; Lerner, L; Marino, K; Orlando, R; Parlee, A; Strymish, J | 1 |
| Babics, A; Roussellier, P | 1 |
| Alm, RA; Le, WJ; Li, S; Liu, YR; Mueller, JP; Rice, PA; Su, XH; Wan, C; Wang, BX | 1 |
| Al-Shahib, A; Alexander, S; Chisholm, SA; Fifer, H; Lythgow, K; Schaefer, U; Tripodo, F; Wilson, J | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Baghai, M; Dworakowski, R; Fife, A; Jenkins, JM | 1 |
| Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC | 1 |
| Antonello, VS; Dallé, J; Jimenez, MF; Kronbauer, K; Riche, CW; Rocha-Castro, J; Santiago, JA | 1 |
| Calum, H; Frimodt-Møller, N; Ghathian, K; Gyssens, IC | 1 |
| Chong, Y; Jeong, SH; Kim, H; Kim, HJ; Lee, H; Lee, K; Suh, YH; Yong, D | 1 |
| Ahn, JY; Kim, MH; Lee, MS; Min, JK; Moon, SY; Park, KH; Son, JS | 1 |
| Arjyal, A; Baker, S; Basnyat, B; Dolecek, C; Dongol, S; Dougan, G; Gajurel, D; Ha Thanh, T; Ho Thi, N; Holt, KE; Karkey, A; Parry, CM; Pham Thanh, D; Pickard, D; Pradhan, A; Rabaa, MA; Shrestha, SK; Thompson, CN; Thwaites, GE; Tran Vu Thieu, N; Voong Vinh, P; Wolbers, M; Wong, V | 1 |
| Anuforom, O; Buckner, MM; Piddock, LJ; Wallace, GR | 1 |
| Cavallaro, MC; Chehter, N; Del Nero, LG; Marta, GN; Zambon, LS | 1 |
| Chestkov, A; Dementieva, E; Deryabin, D; Gryadunov, D; Kubanov, A; Leinsoo, A; Plakhova, X; Shaskolskiy, B; Solomka, V; Vorobyev, D | 1 |
| Qu, K; Rehman, A; Zeng, X | 1 |
| Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
| Ignatius, R; Mertes, T; Regnath, T | 1 |
| Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M | 1 |
| Brunner, A; Jeney, C; Karpati, S; Marschalko, M; Nemes-Nikodem, E; Ostorhazi, E; Szabo, D | 1 |
| Frank, DN; Jobling, MG; Kotter, CV; McCollister, B; Washburn, T | 1 |
| Goeser, F; Hoerauf, A; Kaczmarek, DJ; Krämer, B; Lutz, P; Nattermann, J; Nischalke, HD; Parcina, M; Schlabe, S; Spengler, U; Strassburg, CP | 1 |
| Buckley, C; Chen, M; Donovan, B; Guy, R; Kundu, RL; Lahra, MM; Regan, DG; Trembizki, E; Whiley, DM | 1 |
| Allan-Blitz, LT; Bhatti, A; Hemarajata, P; Humphries, RM; Klausner, JD; Pandori, MW; Siedner, MJ | 1 |
| Dietler, G; Greub, G; Kasas, S; Longo, G; Opota, O; Prod'hom, G; Stupar, P | 1 |
| Araya, P; Borthagaray, G; Carvallo, ME; Corredor, AH; Dillon, JR; Galarza, P; Hernandez, AL; Payares, D; Sanabria Cruz, OM; Thakur, SD | 1 |
| Chen, SC; Chen, XS; Dai, XQ; Han, Y; Yin, Y; Yu, RX; Zhang, GY; Zheng, BJ | 1 |
| Prabha, V; Rishi, P; Singh, AP | 1 |
| Dauger, S; Desselas, E; Duhil de Bénazé, G; Gaschignard, J; Houdouin, V; Kheniche, A; Levy, M; Mariani-Kurkdjian, P; Poncelet, G | 1 |
| Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
| Chakanyuka Musanhu, C; Gudza-Mugabe, M; Gwanzura, L; Latif, AS; Machiha, A; Ndowa, F; Shukusho, FD; Tarupiwa, A; Unemo, M; Wi, T | 1 |
| Ahn, J; Kim, J | 1 |
| Bari, H; Khan, MR; Shariff, AH | 1 |
| Katz, AR; Kersh, EN; Kirkcaldy, RD; Komeya, AY; Kunimoto, GY; Maningas, EV; O'Brien, PS; O'Connor, NP; Papp, JR; Sato, DT; Soge, OO; Tomas, JE; Wasserman, GM; Whelen, AC | 1 |
| Behl, P; Chander, J; Guglani, V; Gupta, V; Sachdev, A | 1 |
| Adams, EJ; Christensen, H; Fifer, H; McAdams, D; McDonnell, A; Turner, KM; Woodford, N | 1 |
| Li, R; Liu, A; Zhao, L; Zhao, S | 1 |
| Baird, RW; Beaman, M; Buckley, C; Chen, M; Donovan, B; Fairley, CK; Freeman, K; Guy, R; Hogan, T; Kaldor, JM; Karimi, M; Kundu, RL; Lahra, MM; Limnios, A; Regan, DG; Ryder, N; Su, JY; Trembizki, E; Ward, J; Whiley, DM | 1 |
| Cheng, F; Li, B; Wang, S; Zhang, J; Zhou, X; Zhu, Z | 1 |
| Ashley, EA; Dittrich, S; González, IJ; Havumaki, J; Ongarello, S; Tadesse, BT; Wijegoonewardena, M | 1 |
| Amato-Gauci, AJ; Cole, MJ; Jacobsson, S; Spiteri, G; Tripodo, F; Unemo, M; Woodford, N | 1 |
| Chesson, HW; Gift, TL; Grad, YH; Hsu, K; Salomon, JA; Tuite, AR | 1 |
| Heather, CS; Maley, M | 1 |
| Gavin, HE; Satchell, KJF; Trinh, SA | 1 |
| Affolabi, D; Ahotin, G; Alary, M; Behanzin, L; Goma, E; Guédou, F; Massou, F; Orekan, J; Sogbo, F | 1 |
| Dillon, JR; Horsman, GB; Levett, PN; Thakur, SD | 1 |
| Hameed, F; Imtiaz, A; Irfan, F; Mirza, IA; Nadeem, S; Zehra, NM | 1 |
| Dance, DAB; Davong, V; Keoluangkhot, V; Mayxay, M; Phouangsouvanh, S; Vongsouvath, M | 1 |
| Hori, M; Ikemachi, M; Isome, K; Iwata, A; Kawasaki, Y; Matsubara, K; Morita, M; Nigami, H; Ohkusu, K; Ohnishi, M; Takahashi, H; Yamamoto, G | 1 |
| Allan-Blitz, LT; Hemarajata, P; Humphries, RM; Klausner, JD; Segura, ER; Wynn, A | 1 |
| Bremer, V; Buder, S; Dudareva, S; Guhl, E; Jansen, K; Kohl, PK; Loenenbach, A; Nikisins, S; Sailer, A | 1 |
| Lukenge, M; Mboowa, G; Mwambi, B; Segujja, F; Sserwadda, I; Walusimbi, A | 1 |
| Johnson-Mitchell, M; Neeb, AD; Simmons, MN | 1 |
| Khalifa, MO; Mansour, MA | 1 |
| Rabadi, MH | 1 |
| Choe, KW; Kim, KH; Lee, H; Lee, K; Seo, Y | 1 |
| Bazzo, ML; Benzaken, AS; Ferreira, WA; Franchini, M; Gaspar, PC; Golfetto, L; Pires, AF; Ramos, MC; Unemo, M | 1 |
| Araya Rodriguez, P; Borthagaray, G; Carvallo, MET; Chiappe, M; Corredor, AH; Cruz, OMS; Dillon, JR; Galarza, P; Hernandez, AL; Martin, I; Martinez, MF; Moreno, JE; Payares, D; Sawatzky, P; Thakur, SD | 1 |
| Booth, JG; Gröhn, YT; Lanzas, C; Love, WJ; Zawack, KA | 1 |
| de Moraes, C; Dias, UJ; Gorla, MC; Lemos, AP; Pinhata, JMW | 1 |
| Aanensen, DM; Abad, R; Abudahab, K; Bercot, B; Borrego, MJ; Cole, MJ; Crowley, B; Goater, R; Golparian, D; Harris, SR; Jacobsson, S; Sánchez-Busó, L; Spiteri, G; Stefanelli, P; Tripodo, F; Unemo, M; Yeats, CA | 1 |
| Cole, MJ; Ison, C; Woodford, N | 1 |
| Adebajo, S; Ake, J; Akintunde, A; Anzick, S; Baral, SD; Barbian, K; Charurat, ME; Crowell, TA; Eluwa, G; Gaydos, CA; Hardick, J; Ivo, A; Lombardi, K; Njab, J; Nowak, RG; Odeyemi, S; Quinn, TC | 1 |
| Calado, J; Campos, MJ; Castro, R; Lopes, Â; Pereira, F; Rocha, M | 1 |
| Kariuki, S; Muigai, AWT; Mutai, WC; Waiyaki, P | 1 |
| Amato-Gauci, AJ; Cole, MJ; Day, MJ; Jacobsson, S; Spiteri, G; Unemo, M; Woodford, N | 1 |
| Frimodt-Møller, N; Haugan, MS; Løbner-Olesen, A | 1 |
| Carr, GJ; Jacobson, RK; Notaro, MJ | 1 |
| Funaishi, K; Hattori, N; Katsutani, S; Kawamoto, K; Matsumoto, N; Matsumoto, Y; Ohashi, N; Taniwaki, M; Yamasaki, M | 1 |
| Chang, H; Kan, B; Li, Y; Wei, Z; Xu, X; Yan, M; Zeng, M | 1 |
| Kim, CM; Kim, DM; Park, HR; Yun, NR | 1 |
| Chan, EWC; Chen, K; Chen, S | 1 |
| Bastian, I; Harch, SAJ; Jennison, AV | 1 |
| Enriquez, RP; George, CRR; Lahra, MM | 1 |
| Amado Fernández, E; Losada Castillo, I; Malvar Pintos, A; Paz Montero, Ó; Pousa Ortega, Á; Purriños-Hermida, MJ | 1 |
| Dahiya, S; Das, BK; Kabra, SK; Kapil, A; Lodha, R; Malik, R; Ohri, VC; Sashi, A; Sharma, P; Sood, S; Walia, K | 1 |
| Keh, S; Lipton, G; Soulsby, H; Tikka, T | 1 |
| Chen, MY; Chow, EPF; De Petra, V; Denham, I; Fairley, CK; Howden, BP; Stevens, K; Williamson, DA | 1 |
| Christensen, H; Hill, D; Homer, M; Horner, P; Hughes, G; Looker, KJ; Ong, JJ; Turner, KME; Verschueren van Rees, N; Zienkiewicz, AK | 1 |
| Card, KJ; Gomez, JB; LaBar, T; Lenski, RE | 1 |
| Majewska, A; Majewski, S; Malejczyk, M; Młynarczyk, G; Młynarczyk-Bonikowska, B | 1 |
| Berntsen, S; Hansen, HL; Jensen, JS; Mulvad, G; Pedersen, ML; Poulsen, P | 1 |
| Abade, AM; Joachim, A; Majigo, MV; Mizinduko, MM; Ngogo, FA; Rumisha, SF | 1 |
| Delarampour, A; Ghalehnoo, ZR; Khademi, F; Vaez, H | 1 |
| Enriquez, RP; Hogan, TP; Lahra, MM | 1 |
| Barbé, B; Deborggraeve, S; Falay, D; Hardy, L; Ingelbeen, B; Jacobs, J; Kalonji, LM; Lunguya, O; Ngonda, D; Phoba, MF; Tack, B; van der Sande, MAB; Van Puyvelde, S | 1 |
| Bogdanic, F; Goto, M; Kobayashi, T; Pujagic, E | 1 |
| Han, L; Ni, Y; Qu, J; Sun, J; Tao, Y; Xie, L; Xu, Y; Zhou, K | 1 |
| Antonitsch, L; Markowicz, M; Stanek, G; Weidinger, G | 1 |
| Assegu Fenta, D; Derese, B; Lemma, K; Tadele, H; Tadesse, BT | 1 |
| Hamill, MM; Kajumbula, H; Kakooza, F; Kyambadde, P; Lamorde, M; Manabe, YC; Mande, E; Mbabazi, O; Mugasha, R; Musinguzi, P; Wagner, J; Walwema, R; Workneh, M; Zenilman, J | 1 |
| Shimekaw, M; Tessema, B; Tigabu, A | 1 |
| Altun, B; Cakar, A; Demirci-Duarte, S; Eser, OK; Gur, D; Sancak, B; Unalan-Altintop, T | 1 |
| Armstrong, BH; George, CRR; Hogan, TR; Lahra, MM; Shoushtari, M | 1 |
| Buder, S; Dudareva, S; Eckardt, M; Gassowski, M; Graeber, I; Guhl, E; Heuer, D; Jansen, K; Selb, R; Tamminga, T | 1 |
| Hogan, TR; Lahra, MM | 1 |
| Ahn, J; Jeon, G | 1 |
| Alper, CM; Bruk, LA; Dunkelberger, KE; Fedorchak, MV; Hong, W; Khampang, P; Sadagopan, S | 1 |
| Bernal Andres, B; Gonzalez Moreno, M; Tkhilaishvili, T; Trampuz, A; Wang, L | 1 |
| Hogan, TR; Lahra, MM; Shoushtari, M | 1 |
| Aanensen, D; Ahlstrand, J; Cole, MJ; Day, M; Golparian, D; Jacobsson, S; Sánchez-Busó, L; Unemo, M | 1 |
| Alcoceba, E; Arando, M; Bernal, S; Colomina, J; Idigoras, P; Leal-Negredo, Á; Martin-Saco, G; Martínez, O; Menéndez, B; Romero, B; Salmerón, P; Serra-Pladevall, J; Torreblanca, A; Viñado, B | 1 |
| Cole, MJ; Day, M; Jacobsson, S; Spiteri, G; Unemo, M | 1 |
| Chan, EW; Chen, K; Chen, S; Yang, C | 1 |
| Fifer, H; Findlater, L; Geffen Obregon, O; Gobin, M; Mohammed, H; Ross, J; Turner, KME | 1 |
| Ding, CH; Esa, H; Hameed, AA; Norazlah, B; Wahab, AA | 1 |
| Bodmer, T; Egli, K; Flückiger, U; Risch, L; Risch, M; Roditscheff, A | 1 |
| Allen, GP; Deao, KM; Hill, SA; Schipelliti, SM; Tran, T | 1 |
| Anzinger, JJ; Barrow, GJ; Cameron-McDermott, SM; De La Haye, CO; Lewis, VM; Miller, ZN; Nicholson, A; Otto-Stewart, N; Reynolds-Campbell, GY; Roye-Green, KJ; Skyers, N; Thoms-Rodriguez, CA; Tomlinson, JA; Unemo, M; Webster, AM; Wood, DHE | 1 |
| Bonongwe, N; Chen, JS; Chikaonda, T; Cohen, MS; Golparian, D; Hobbs, MM; Hoffman, IF; Jere, E; Kamtambe, B; Krysiak, R; Massa, C; Mathiya, E; Matoga, M; Ndalama, B; Unemo, M | 1 |
| Bai, X; Borrow, R; Clark, SA; Lee-Jones, L; Lekshmi, A; Lucidarme, J; Walker, A; Walsh, L; Willerton, L | 1 |
| Chen, W; Feng, Z; Liao, Y; Lin, X; Qin, X; Tang, S; Wu, X; Xie, Q; Yu, Y; Zheng, H | 1 |
| Álvarez Del Vayo-Benito, C; Catillo-Salinas, F; Comuñas, J; Dolz, E; Fernández-Llamazares, CM; Fernández-Polo, A; Gallego-Fernández, C; Gázquez-Pérez, R; Gil-Navarro, MV; Gómez-Trevecedo Calvo, MT; González-López, M; Jiménez-Parrilla, F; Manrique-Rodríguez, S; Montecatine-Alonso, E; Villanueva-Bueno, C; Zamora-Flores, E | 1 |
| Green, MD; Khanthavong, M; Mayxay, M; Newton, PN; Phonlavong, C; Sengaloundeth, S; Sichanh, C; Swamidoss, I; Tabernero, P; Vilayhong, C | 1 |
| Barkalita, LM; Borah, P; Choudhury, M; Das, L; Deka, NK; Dutta, R; Hazarika, G; Hussain, MI; Malakar, D | 1 |
| De Baetselier, I; De Block, T; Gonzalez, N; Kenyon, C; Laumen, J; Manoharan-Basil, SS; Van Dijck, C; Vanbaelen, T | 1 |
| Abu-Raddad, LJ; Al Khal, A; Al Romaihi, HE; Al-Maslamani, M; Al-Thani, MH; Chemaitelly, H; Elmagboul, EBI; Puthiyottil, A; Unemo, M; Varghese, MK | 1 |
| Abirami, BS; Alexander, AP; Amladi, A; Anandan, S; Bakthavatchalam, YD; Bavdekar, A; De, A; Dutta, S; Evelyn Ebenezer, S; Gupta, M; Jacob, JJ; Jinka, DR; John, J; Kang, G; Kapil, A; Koshy, RM; More, D; Nagaraj, S; Nayakanti, RR; Perumal, SPB; Pragasam, AK; Ray, P; Rongsen-Chandola, T; Saigal, K; Sanghavi, S; Sethuvel, DPM; Shastri, J; Singh, A; Thomas, M; Veeraraghavan, B | 1 |
| Blain, AE; Hu, F; Marjuki, H; McNamara, LA; Potts, CC; Retchless, AC; Rodriguez-Rivera, LD; Wang, X | 1 |
| Daneman, N; Elligsen, M; Katz, K; Lam, PW; Lo, J; MacFadden, D; Teitelbaum, D; Vermeiren, C | 1 |
| Aghaei, A; Ahmadi, E; Ahmadi, S; Derakhshan, S; Nasseri, S | 1 |
| Abraham, R; Abraham, S; Barlow, R; Duffy, L; Hampson, DJ; Jordan, D; McMillan, K; Mellor, G; O'Dea, M; Sahibzada, S | 1 |
| Kamiya, H; Kobayashi, A; Mahazu, S; Morita, M; Nakajima, J; Ohnishi, M; Ota, Y; Prah, I; Saito, R; Takahashi, H; Tohda, S | 1 |
| Jin, Y; Kaviar, VH; Kouhsari, E; Li, YM; Maleki, A; Omidi, N; Vaziri, AZ; Yuan, XH | 1 |
| Barazzetti, FH; Bazzo, ML; de Albuquerque, VCB; de Melo Machado, H; Golfetto, L; Martins, JM; Santos, TMD; Scheffer, MC; Schörner, MA | 1 |
| Cole, MJ; Dillon, JR; Eremin, S; Escher, M; Galarza, P; Galas, M; Lahra, MM; Martin, I; Ndowa, F; Ramon-Pardo, P; Unemo, M; Weinstock, H; Wi, T | 1 |
| Bekal, S; Bernaquez, I; Gaudreau, C; Goyette, A; Pilon, PA; Yared, N | 1 |
| Amato-Gauci, AJ; Blumel, B; Cole, MJ; Day, MJ; Jacobsson, S; Kulishev, C; Sajedi, N; Spiteri, G; Unemo, M; van der Werf, MJ; Woodford, N | 1 |
| Baklouti, S; De Riols, P; Gandia, P; Garrigues, JC; Lanot, T; Lavit, M; Mané, C; Ruiz, S; Seraissol, P | 1 |
| Adamson, PC; Allan-Blitz, LT; Klausner, JD | 1 |
| Barrios-Cárdenas, YJ; Benites, C; Jorge-Berrocal, A; Mayta-Barrios, M; Melano, RG; Salazar-Quispe, F; Vargas-Herrera, N; Yagui, M | 1 |
| Chang, J; He, S; Hu, M; Qin, X; Shi, C; Shi, X; Xu, X; Zhang, Z; Zhou, M | 1 |
| Al Atbee, MYN; Jalil, MB | 1 |
| Aleksic Sabo, V; Cvetanovic, J; Gavric, D; Gostimirovic, S; Knezevic, P; Narancic, J; Nikolic, I; Vukovic, D | 1 |
| Jenjaroenpun, P; Nitayanon, P; Nokchan, N; Tribuddharat, C; Wongsurawat, T | 1 |
| Chang, YJ; Chen, CL; Chiu, CH; Lee, CC; Liu, FC; Yang, HP | 1 |
| Kwenda, G; Maimbolwa, MC; Munsaka, SM; Ngalamika, O; Sarenje, KL; Siame, A | 1 |
| Abbasi, SA; Ali, S; Andleeb, S; Awan, UA; Imdad, K; Mughal, TA; Nasreen, S; Raja, SA | 1 |
| Armstrong, BH; Hogan, TR; Lahra, MM | 1 |
| Götz, HM; van Benthem, BH; van Dam, AP; Visser, M | 1 |
| Chen, M; Gao, H; Jia, C; Li, R; Lin, D; Lin, X; Qiu, Y; Shan, Q; Song, W; Tong, J; Wan, C; Wang, C; Wu, S; Xu, Y; Yang, J; Zeng, M; Zhao, S; Zhu, C; Zhu, Y; Zhuo, Z | 1 |
| Kiamos, A; Sands, M; Torrente, N; Verdecia, J | 1 |
| Assenga, EN; Godfrey, E; Majaliwa, E | 1 |
| Debelo, M; Mohammed, N; Tiruneh, A; Tolosa, T | 1 |
| Abboud, P; Alexis, JF; Djossou, F; Epelboin, L; Kheng, M; Malmontet, T; Mosnier, É; Pierre Demar, M; Roques, F; Tauch, V; Vesin, G; Walter, G | 1 |
| Abbas Tikki, K; Hayder Hasan, T; Sabah Bustani, G; Sadeq Al-Ethari, A | 1 |
| Abdul Ameer Al-Kraety, I; Ghani Al-Muhanna, S; Maki N Al-Muaala, A; Sadeq Yasir Al-Ethari, A | 1 |
| Ali, MEM; Gomaa, E; Mohammed, R; Mohsen, M | 1 |
| Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A | 1 |
| Deng, B; Li, S; Li, Z; Shui, Y; Wu, P; Zhang, J; Zhang, W | 1 |
| Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
| Abbott, IJ; Cottingham, H; Macesic, N; Meletiadis, J; Peleg, AY; Roberts, JA; van Gorp, E; Wallis, SC | 1 |
| Kreisel, KM; Nielsen, KE; Pham, CD; St Cyr, SB | 1 |
| Baik, SK; Han, KH; Heo, J; Heo, NY; Jung, YK; Kang, SH; Kim, BI; Kim, HS; Kim, MY; Kim, TH; Kim, YS; Park, JY; Park, SY; Seo, YS; Sohn, JH; Suh, SJ; Um, SH; Yim, HJ; Yim, SY | 1 |
| Abdullah, S; Mohsin, M; Muhammad, F; Rahman, SU | 1 |
| Ölmez, S; Otlu, B; Sancak, B; Şener, B | 1 |
| Abbasian, S; Alesaeidi, S; Amiriani, T; Baharvand, A; Kiaei Sudkolaei, M; Kouhsari, E; Mashatan, N; Molaeipour, L; Shaddel, R; Talib Al-Naqeeb, BZ | 1 |
| Ahmad, M; Shah, N; Siddiqui, MA | 1 |
| Ghani, I; Hussain, W; Khurshaid, U; Mirza, IA; Niaz, Z; Zaman, G | 1 |
| Chung, CR; Horng, JT; Lee, TY; Lu, JJ; Wang, HY; Wu, LC; Yao, CH | 1 |
| Antonio, M; Awuor, AO; Badji, H; Doh, S; Focht, C; Hossain, MJ; Houpt, E; Jones, J; Jones, JCM; Juma, J; Kasumba, IN; Kotloff, KL; Liu, J; Nasrin, D; Nasrin, S; Ochieng, JB; Omore, R; Permala-Booth, J; Platts-Mills, JA; Powell, H; Roose, A; Sen, S; Sow, SO; Sugerman, CE; Tennant, SM; Verani, JR; Watson, N; Widdowson, MA; Zaman, SMA | 1 |
| Allen, H; Althaus, CL; Cole, MJ; Grad, YH; Heijne, JCM; Low, N; Riou, J; Unemo, M | 1 |
| Abe, R; Ram-Mohan, N; Tjandra, KC; Wang, TH; Yang, S | 1 |
| Broner, S; Ciruela, P; Cruells, A; Esteve, S; Ferré, L; Herrero, M; Jané, M; Mendioroz, J | 1 |
| Bi, C; Cao, W; Li, X; Liang, J; Liu, W; Yu, Y; Zhang, X | 1 |
| Archuleta, S; Chan, M; Cher, BP; Ding, Y; Fisher, D; Izharuddin, E; Kalimuddin, S; Lee, TH; Low, J; Lye, DC; Molton, JS; Moorakonda, R; Oon, J; Phillips, R; Salada, BMA; Wei, Y; Wijaya, LM; Yoong, J; Young, B; Yuen, KH | 1 |
| Bell, SFE; Lahra, MM; Lewis, DA; Ware, RS; Whiley, DM | 1 |
| Gelaye, A; McClellan, B; Patel, K; Small, D; Steinberger, J | 1 |
| Bhattarai, KH; Fang, H; Vestberg, N | 1 |
| Blouin, K; Defay, F; Ezin Aloffan, LND; Labbé, AC; Lefebvre, B; Perrault Sullivan, G; Trudelle, A | 1 |
| Du, X; Han, Y; Li, X; Liu, H; Liu, M; Qiu, S; Song, H; Xiang, Y; Xu, X; Yang, C; Yang, H; Zhu, K | 1 |
| Hogan, TR; Lahra, MM; Van Hal, S | 1 |
| Bamford, C; Gigi, R; Jung, H; Martinez, FP; Mdingi, MM; Mitchev, N; Peters, RPH; Shroufi, A | 1 |
| Dingle, TC; Ferrato, C; Gratrix, J; Ma, A; Martin, I; Smyczek, P | 1 |
24 review(s) available for ciprofloxacin and ro13-9904
| Article | Year |
|---|---|
The chemoprophylaxis of meningococcal infection.
Topics: Anti-Bacterial Agents; Carrier State; Ceftriaxone; Ciprofloxacin; Half-Life; Humans; Meningococcal Infections; Pharynx; Rifampin; Risk Factors | 1988 |
Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
Topics: Adolescent; Adult; Bacterial Vaccines; Canada; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Communicable Disease Control; Female; Humans; Infant; Infant, Newborn; Meningococcal Infections; Meningococcal Vaccines; Pregnancy; Public Health; Rifampin; Vaccination | 1994 |
Chancroid.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Chancroid; Ciprofloxacin; Erythromycin; HIV Infections; Humans | 1996 |
Chronic relapsing salmonella osteomyelitis in an immunocompetent patient: case report and literature review.
Topics: Adult; Anti-Infective Agents; Cefazolin; Ceftriaxone; Cephalosporins; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Floxacillin; Humans; Immunocompetence; Male; Osteomyelitis; Penicillins; Recurrence; Salmonella; Salmonella Infections; Time Factors | 2002 |
[Changing epidemiological profile and treatment of syphilis and gonorrhea].
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Contact Tracing; Drug Resistance, Bacterial; Female; Finland; Gonorrhea; Humans; Penicillin G Procaine; Pregnancy; Pregnancy Complications, Infectious; Syphilis | 2002 |
Successful management of disseminated Nocardia transvalensis infection in a heart transplant recipient after development of sulfonamide resistance: case report and review.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cardiomyopathy, Dilated; Ceftriaxone; Ciprofloxacin; Drug Resistance; Heart Transplantation; Humans; Male; Middle Aged; Nocardia; Nocardia Infections; Outcome Assessment, Health Care; Postoperative Complications; Sulfonamides | 2003 |
[Endocarditis due to Bartonella spp. Three new clinical cases and Spanish literature review].
Topics: Actinobacillus Infections; Adult; Aged; Aggregatibacter actinomycetemcomitans; Alcoholism; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve; Bartonella henselae; Bartonella Infections; Blood; Cardiomyopathy, Hypertrophic; Cat-Scratch Disease; Cats; Ceftriaxone; Chlamydia; Ciprofloxacin; Combined Modality Therapy; Disease Susceptibility; Doxycycline; Endocarditis, Bacterial; Endocarditis, Subacute Bacterial; False Negative Reactions; Female; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Spain; Vancomycin | 2006 |
Clinical practice. Prevention of meningococcal disease.
Topics: Adolescent; Adult; Anti-Infective Agents; Ceftriaxone; Child; Ciprofloxacin; Disease Outbreaks; Humans; Male; Meningococcal Infections; Meningococcal Vaccines; Neisseria meningitidis; Practice Guidelines as Topic; Rifampin; United States; Vaccines, Conjugate | 2006 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2006 |
Infective endocarditis caused by Salmonella enteritidis in a dialysis patient: a case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Female; Humans; Renal Dialysis; Salmonella enteritidis; Salmonella Infections | 2009 |
[Could it be bacterial meningitis?].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Community-Acquired Infections; Critical Care; Enzyme Inhibitors; Hospitalization; Humans; Meningitis, Bacterial; Neisseria meningitidis; Prognosis; Rifampin; Streptococcus pneumoniae; Tomography, X-Ray Computed | 2006 |
Antibiotics for the treatment of dysentery in children.
Topics: Amdinocillin Pivoxil; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Dysentery; Dysentery, Bacillary; Female; Humans; Infant; Male; Randomized Controlled Trials as Topic; Salmonella Infections; Shigella dysenteriae; Treatment Outcome | 2010 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2011 |
[Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisseria gonorrhoeae | 2013 |
Antibiotics for preventing meningococcal infections.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Minocycline; Neisseria meningitidis; Randomized Controlled Trials as Topic; Rifampin | 2013 |
Antimicrobial resistance in Africa: a systematic review.
Topics: Africa; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Neisseria gonorrhoeae | 2017 |
Prevertebral neck abscess with
Topics: Abscess; Ceftriaxone; Ciprofloxacin; Diabetes Mellitus, Type 2; Drainage; Humans; Male; Metronidazole; Middle Aged; Neck; Salmonella enterica; Salmonella Infections; Sepsis; Treatment Outcome | 2019 |
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Genotype; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillins | 2020 |
Typhoid fever presenting as acute psychosis in a young adult: case report and literature review of typhoid psychosis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Male; Psychotic Disorders; Salmonella typhi; Typhoid Fever; Young Adult | 2021 |
Global epidemiology of antimicrobial resistance in commensal Neisseria species: A systematic review.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria; Neisseria gonorrhoeae | 2022 |
Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cholera; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae O1; Vibrio cholerae O139 | 2022 |
[Sacroiliitis with
Topics: Animals; Ceftriaxone; Ciprofloxacin; Endocarditis; Erysipelothrix; Erysipelothrix Infections; Female; Humans; Middle Aged; Sacroiliitis | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
The increasing antimicrobial resistance of
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Humans; Iran; Microbial Sensitivity Tests; Shigella | 2023 |
25 trial(s) available for ciprofloxacin and ro13-9904
| Article | Year |
|---|---|
A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.
Topics: Administration, Oral; Aged; Aged, 80 and over; Bronchitis; Ceftriaxone; Ciprofloxacin; Cross Infection; Drug Administration Schedule; Female; Haemophilus Infections; Haemophilus influenzae; Homes for the Aged; Humans; Injections, Intravenous; Male; Nursing Homes; Pneumonia; Sputum; Streptococcal Infections; Survival Rate | 1991 |
Oral ciprofloxacin versus ceftriaxone for the treatment of urethritis from resistant Neisseria gonorrhoeae in Zambia.
Topics: Adult; Ceftriaxone; Chlamydia trachomatis; Ciprofloxacin; Double-Blind Method; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Randomized Controlled Trials as Topic; Urethritis; Zambia | 1990 |
Antibiotic prophylaxis in biliary tract surgery. Ciprofloxacin versus ceftriaxone.
Topics: Bacterial Infections; Bile; Biliary Tract Surgical Procedures; Ceftriaxone; Ciprofloxacin; Female; Humans; Male; Middle Aged; Postoperative Complications; Premedication | 1989 |
Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin.
Topics: Adolescent; Adult; Carrier State; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; Humans; Nasopharynx; Neisseria meningitidis; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Rural Health | 1995 |
Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever.
Topics: Bacteriophage Typing; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Humans; Treatment Outcome; Typhoid Fever | 1993 |
Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women.
Topics: Adolescent; Adult; Ceftriaxone; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Gonorrhea; Humans; Injections, Intramuscular; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Prospective Studies | 1993 |
Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients.
Topics: Administration, Oral; Adult; Ceftriaxone; Ciprofloxacin; Clindamycin; Double-Blind Method; Doxycycline; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Laparoscopy; Pelvic Inflammatory Disease | 1997 |
Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Fever; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Neutropenia; Outpatients; Prospective Studies; Treatment Outcome | 1999 |
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Amoxicillin; Antineoplastic Agents; Bacteremia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Prospective Studies; Survival Rate | 1999 |
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Anti-Infective Agents; Antineoplastic Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Fever; Humans; Neoplasms; Neutropenia; Prospective Studies; Risk Factors | 2000 |
Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Injections, Intramuscular; Male; Prospective Studies | 2000 |
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Argentina; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Humans; Infant; Leukemia; Male; Neutropenia; Risk | 2003 |
Antibiotic therapy for diabetic foot infections: comparison of cephalosporines with chinolones.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Diabetic Foot; Female; Humans; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2004 |
Short-term antibiotic prophylaxis in implant surgery: a comparison of three antibiotics.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftriaxone; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prosthesis-Related Infections; Treatment Outcome | 2007 |
Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ceftriaxone; Ciprofloxacin; Humans; Male; Middle Aged; Prospective Studies; Prostate; Prostatic Neoplasms; Rectum; Risk Assessment; Urinary Tract Infections | 2008 |
A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Ceftriaxone; Ciprofloxacin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Fever; Greece; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome | 2008 |
The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Infant; Meningitis, Bacterial; Nutritional Status; Prognosis; Prospective Studies; Recurrence; Salmonella Infections; Treatment Outcome | 2009 |
Comparison of infection and urosepsis rates of ciprofloxacin and ceftriaxone prophylaxis before percutaneous nephrolithotomy: a prospective and randomised study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftriaxone; Ciprofloxacin; Female; Humans; Male; Middle Aged; Nephrostomy, Percutaneous; Postoperative Complications; Sepsis; Time Factors | 2012 |
Oral versus intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: study protocol for a randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Clinical Protocols; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Hospital Costs; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Quality of Life; Research Design; Singapore; Time Factors; Treatment Outcome | 2013 |
To study the role of antibiotic+steroid irrigation of the middle ear in active chronic otitis media with small perforation and pulsatile discharge.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Dexamethasone; Follow-Up Studies; Glucocorticoids; Humans; Middle Aged; Otitis Media, Suppurative; Prospective Studies; Single-Blind Method; Suction; Therapeutic Irrigation; Treatment Outcome; Tympanic Membrane Perforation; Young Adult | 2014 |
A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Genotype; Humans; Nepal; Salmonella typhi; Sequence Analysis, DNA; Treatment Failure; Typhoid Fever | 2016 |
Antibiotic prophylaxis in transarterial chemoembolization of hepatocellular carcinoma.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carcinoma, Hepatocellular; Catheterization, Peripheral; Ceftriaxone; Chemoembolization, Therapeutic; Ciprofloxacin; Drug Administration Routes; Drug Monitoring; Egypt; Female; Humans; Levofloxacin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Treatment Outcome | 2018 |
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Gonorrhea; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2021 |
Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ascites; Bacterial Infections; Cefotaxime; Ceftriaxone; Ciprofloxacin; End Stage Liver Disease; Humans; Liver Cirrhosis; Middle Aged; Peritonitis; Prospective Studies; Severity of Illness Index; Young Adult | 2023 |
Cost-minimization analysis of oral versus intravenous antibiotic treatment for Klebsiella pneumoniae liver abscess.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Costs and Cost Analysis; Humans; Klebsiella pneumoniae; Liver Abscess | 2023 |
389 other study(ies) available for ciprofloxacin and ro13-9904
| Article | Year |
|---|---|
Multi-drug-resistant Salmonella typhi--a need for therapeutic reappraisal.
Topics: Cefotaxime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Infant; Male; Salmonella typhi; Typhoid Fever | 1992 |
Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.
Topics: Adult; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Half-Life; Humans; Imipenem; Male; Microbial Sensitivity Tests | 1992 |
Successful medical management of a patient with multiple hepatic abscesses due to Edwardsiella tarda.
Topics: Adult; Ceftriaxone; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Imipenem; Liver Abscess; Male | 1992 |
Effect of short-term therapy with ciprofloxacin, ceftriaxone and placebo on human peripheral WBC and marrow-derived granulocyte-macrophage progenitor cells (CFU-GM)
Topics: Ceftriaxone; Ciprofloxacin; Colony-Forming Units Assay; Drug Administration Schedule; Granulocytes; Hematopoiesis; Humans; Leukocyte Count; Macrophages | 1992 |
Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Blood Bactericidal Activity; Ceftriaxone; Ciprofloxacin; Complement System Proteins; Enzyme-Linked Immunosorbent Assay; Epitopes; Escherichia coli; Escherichia coli Infections; Female; Immunization; Immunoglobulin G; Immunoglobulin M; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Netilmicin; Opsonin Proteins; Phagocytosis | 1991 |
[Transitory bacteremia caused by Neisseria meningitidis group B with an intermediate sensitivity to penicillin].
Topics: Bacteremia; Ceftriaxone; Ciprofloxacin; Female; Humans; Middle Aged; Neisseria meningitidis; Neisseriaceae Infections; Penicillin Resistance; Penicillins | 1991 |
Treatment of nursing home-acquired pneumonia.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Cross Infection; Homes for the Aged; Humans; Nursing Homes; Pneumonia; United States | 1991 |
In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Enterobacteriaceae Infections; Fleroxacin; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
[The in vitro activity of ciprofloxacin against clinically-isolated strains of Pseudomonas aeruginosa and comparison with some other antibiotics].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Ceftriaxone; Ciprofloxacin; Gentamicins; Humans; Ofloxacin; Pseudomonas aeruginosa | 1990 |
Therapy of pulmonary nocardiosis in immunocompromised mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Cortisone; Female; Humans; Imipenem; Immunity, Cellular; Immunologic Deficiency Syndromes; Lung Diseases; Mice; Nocardia asteroides; Nocardia Infections; Sulfadiazine | 1990 |
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 1989 |
Ciprofloxacin vs ceftriaxone for eradication of meningococcal carriage.
Topics: Carrier State; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections | 1988 |
In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis.
Topics: Anti-Bacterial Agents; Brucella; Brucellosis; Ceftriaxone; Ciprofloxacin; Drug Combinations; Humans; Microbial Sensitivity Tests; Quinolines; Sulfamethoxazole; Tetracyclines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Comparative efficacy of ciprofloxacin and ceftriaxone in experimental arthritis caused by Escherichia coli.
Topics: Animals; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Escherichia coli Infections; Female; Quinolines; Rabbits; Synovial Fluid | 1986 |
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
Topics: Cefmenoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Erythromycin; Fleroxacin; Haemophilus ducreyi; Humans; Neisseria gonorrhoeae; Penicillins; Spectinomycin; Tetracycline | 1987 |
The effect of anaerobiosis on antistaphylococcal antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anaerobiosis; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Clavulanic Acids; Clindamycin; Coagulase; Drug Therapy, Combination; Glycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Ticarcillin; Tobramycin; Vancomycin | 1988 |
Oral fluoroquinolone therapy in Clostridium difficile enterocolitis.
Topics: Aged; Ceftriaxone; Ciprofloxacin; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male | 1988 |
Ciprofloxacin inhibition of cefoxitin betalactamase induction in an Enterobacter cloacae strain.
Topics: beta-Lactamases; Cefoxitin; Ceftriaxone; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Enzyme Induction; Microbial Sensitivity Tests | 1987 |
[Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Salmonella | 1995 |
Simultaneous infection by a sensitive and a multiresistant strain of Salmonella paratyphi A.
Topics: Adult; Animals; Blastocystis Infections; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Male; Metronidazole; Paratyphoid Fever; Salmonella paratyphi A; Species Specificity; Travel; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.
Topics: Adult; Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Recurrence; Salmonella enteritidis; Salmonella Infections; Tuberculosis, Hepatic | 1995 |
Concurrent falciparum malaria and Salmonella bacteremia in travelers: report of two cases.
Topics: Adult; Bacteremia; Ceftriaxone; Ciprofloxacin; Follow-Up Studies; Humans; Malaria, Falciparum; Male; Quinine; Salmonella Infections; Tetracycline; Travel | 1995 |
Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Antigens, Surface; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Borrelia burgdorferi Group; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Female; Lipoproteins; Lyme Disease; Male; Mice; Mice, Inbred C3H; Polymerase Chain Reaction | 1994 |
Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group.
Topics: Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillins; Species Specificity; Spectinomycin; Tetracycline; United States | 1993 |
In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Topics: Anti-Bacterial Agents; Ceftriaxone; Chancroid; Ciprofloxacin; Erythromycin; Haemophilus ducreyi; Humans; Male; Microbial Sensitivity Tests; Trimethoprim | 1993 |
Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.
Topics: Amines; Anti-Infective Agents; Bacterial Proteins; Carrier Proteins; Cefotaxime; Ceftriaxone; Cell Nucleus; Cephalosporins; Ciprofloxacin; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1993 |
Salmonella: a rare cause of meningitis in an adult.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Humans; Immunocompromised Host; Lupus Erythematosus, Systemic; Meningitis, Bacterial; Middle Aged; Salmonella Infections | 1995 |
In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Disease Outbreaks; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin Resistance; Rifampin | 1995 |
Ciprofloxacin resistant Neisseria gonorrhoea in New Zealand.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; New Zealand | 1996 |
Secondary prevention of meningococcal disease. Ceftriaxone or ciprofloxacin should be considered as first line prophylaxis.
Topics: Ceftriaxone; Ciprofloxacin; Humans; Meningitis, Meningococcal; Meningococcal Infections | 1996 |
Mycotic aneurysm due to non-typhi salmonella: report of 16 cases.
Topics: Aged; Ampicillin; Aneurysm, Infected; Anti-Bacterial Agents; Arteriosclerosis; Bacteremia; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Mortality; Penicillins; Retrospective Studies; Salmonella; Salmonella Infections; Seroepidemiologic Studies; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration.
Topics: Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Evaluation Studies as Topic; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sensitivity and Specificity; Tetracycline | 1996 |
Changing spectrum of typhoid.
Topics: Adolescent; Adult; Anti-Infective Agents; Bone Marrow Examination; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Humans; Male; Sensitivity and Specificity; Typhoid Fever | 1996 |
Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Vaccines; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Contraindications; Humans; Infant; Meningococcal Infections; Meningococcal Vaccines; Neisseria meningitidis; Rifampin; Vaccination | 1997 |
Decreasing trend of multiresistant Salmonella typhi in Bangladesh.
Topics: Ampicillin; Bangladesh; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple; Humans; Longitudinal Studies; Salmonella Infections; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Is it possible to prevent bacterial adhesion onto ureteric stents?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Bacteriological Techniques; Ceftriaxone; Cephalosporins; Ciprofloxacin; Escherichia coli; Humans; Materials Testing; Stents; Tobramycin; Ureter; Urinary Tract Infections | 1997 |
Emerging drug resistance and vaccination for typhoid fever.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella typhi; Typhoid Fever | 1998 |
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Netherlands; Penicillinase; Prevalence; Retrospective Studies; Tetracycline Resistance | 1997 |
Transferable trimethoprim resistance in Shigella strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Conjugation, Genetic; Drug Therapy, Combination; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Plasmids; Shigella; Trimethoprim; Trimethoprim Resistance | 1998 |
Perioperative antibiotic prophylaxis in abdominal surgery for hernia repair: retrospective study of 1,524 consecutive patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Herniorrhaphy; Humans; Male; Middle Aged; Pefloxacin; Retrospective Studies; Surgical Wound Infection; Treatment Outcome | 1998 |
Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Feces; Female; Intestinal Diseases; Mice; Mice, Inbred BALB C; Yersinia enterocolitica; Yersinia Infections | 1998 |
[Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Penicillin Resistance; Penicillins; Rifampin; Spiramycin | 1998 |
Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village.
Topics: Adolescent; Adult; Age Distribution; Anti-Infective Agents; Antibiotic Prophylaxis; Carrier State; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Humans; Incidence; Infant; Infant, Newborn; Israel; Meningococcal Infections; Neisseria meningitidis; Pharynx; Rural Health | 1998 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Comparative in-vitro activity of moxifloxacin, penicillin, ceftriaxone and ciprofloxacin against pneumococci isolated from meningitis.
Topics: Anti-Bacterial Agents; Aza Compounds; Ceftriaxone; Ciprofloxacin; Fluoroquinolones; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Moxifloxacin; Penicillins; Pneumococcal Infections; Quinolines; Streptococcus pneumoniae | 1999 |
Construction of mutant strains of Neisseria gonorrhoeae lacking new antibiotic resistance markers using a two gene cassette with positive and negative selection.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Cloning, Molecular; Drug Resistance, Microbial; Escherichia coli Proteins; Genetic Markers; Humans; Male; Models, Genetic; Mutagenesis, Insertional; Neisseria gonorrhoeae; Plasmids; Polymerase Chain Reaction; Ribosomal Protein S9; Ribosomal Proteins; Transformation, Genetic | 1999 |
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Topics: Animals; Anti-Infective Agents; Catheterization; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Rats; Streptococcal Infections; Streptococcus; Streptococcus sanguis; Treatment Outcome | 1999 |
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Breast Feeding; Ceftriaxone; Chancroid; Ciprofloxacin; Contraindications; Erythromycin; Female; Genital Diseases, Female; Genital Diseases, Male; Haemophilus ducreyi; Humans; Male; Pregnancy; Pregnancy Complications, Infectious; Ulcer | 1999 |
National guideline for the management of epididymo-orchitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Ceftriaxone; Chlamydia trachomatis; Ciprofloxacin; Doxycycline; Epididymitis; Humans; Male; Neisseria gonorrhoeae; Ofloxacin; Orchitis; Sexually Transmitted Diseases | 1999 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; Genital Diseases, Male; Humans; Male; Ofloxacin; Pelvic Inflammatory Disease; Peritonitis; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases | 1999 |
Resistance of Neisseria gonorrhoeae epidemic strains to antibiotics: report of resistant isolates and surveillance in Zhanjiang, China: 1998 to 1999.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Streptomycin; Tetracycline | 2000 |
Trend of antimicrobial resistance in Neisseria gonorrhoeae at New Delhi, India.
Topics: Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Tetracycline; Time Factors | 2000 |
Comparative therapeutic efficacy of clinafloxacin in a pneumococcal meningitis mouse model.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Fluoroquinolones; Meningitis, Pneumococcal; Mice; Microbial Sensitivity Tests; Models, Biological; Streptococcus pneumoniae | 2000 |
Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis.
Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Taiwan; Vancomycin | 2000 |
Pasteurella multocida: a case report of bacteremic pneumonia and 10-year laboratory review.
Topics: Aged; Animals; Ceftriaxone; Cephalosporins; Ciprofloxacin; Dogs; Humans; Male; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Zoonoses | 2000 |
[Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
Topics: Adolescent; Adult; Bacterial Vaccines; Carrier State; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Humans; Incidence; Infant; Meningococcal Infections; Meningococcal Vaccines; Microbial Sensitivity Tests; National Health Programs; Neisseria meningitidis; Rifampin; Spain; Sulfadiazine; Time Factors; Vaccination | 2000 |
[Impossible treatment of gonorrhea].
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Denmark; Drug Costs; Gonorrhea; Humans | 2000 |
Analysis of the antibiotic sensitivity of Neisseria gonorrhoeae in Guangzhou, Peoples Republic of China.
Topics: Anti-Bacterial Agents; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Spectinomycin; Tetracycline | 2000 |
Antibiotics for Salmonella meningitis in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Salmonella Infections | 2000 |
The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Cytokines; Fluoroquinolones; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Naphthyridines; RNA, Messenger; Teichoic Acids | 2000 |
Relapse of multiresistant Salmonella typhi after combined therapy with ciprofloxacin and ceftriaxone.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Recurrence; Salmonella typhi; Typhoid Fever | 2000 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Guyana; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Prevalence; Saint Vincent and the Grenadines; Spectinomycin; Tetracycline Resistance; Trinidad and Tobago | 2001 |
Ciprofloxacin susceptible Salmonella typhi with treatment failure.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Humans; India; Microbial Sensitivity Tests; Salmonella typhi; Treatment Failure; Typhoid Fever | 2001 |
Transfusion-mediated Yersinia enterocolitica septicemia in an adult patient with beta-thalassemia.
Topics: Adult; Anti-Infective Agents; beta-Thalassemia; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Humans; Transfusion Reaction; Treatment Outcome; Yersinia enterocolitica; Yersinia Infections | 2001 |
Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gonorrhea; Health Behavior; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillinase; Penicillins; Prevalence; Spectinomycin; Tetracycline; Tetracycline Resistance; Trinidad and Tobago | 2001 |
Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Humans; Typhoid Fever | 2001 |
Diagnostic dilemma in coinfection.
Topics: Adolescent; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Entamoebiasis; Female; Humans; Methicillin Resistance; Peritonsillar Abscess; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Typhoid Fever | 2001 |
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin | 2002 |
What about antibiotic resistance in Neisseria lactamica?
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Neisseria; Neisseriaceae Infections; Penicillins; Rifampin | 2002 |
Meningococcemia following tonsillectomy.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Male; Meningococcal Infections; Postoperative Complications; Tonsillectomy | 2001 |
Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Fever; Humans; Neoplasms; Neutropenia; Risk Factors | 2002 |
[Comment on Borrelia burgdorferi Group infections].
Topics: Antibodies, Bacterial; Borrelia burgdorferi Group; Ceftriaxone; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Humans; Josamycin; Lyme Disease | 2002 |
Intracranial infection due to non-typhoidal Salmonella: report of four cases.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Central Nervous System Bacterial Infections; Cephalosporins; Ciprofloxacin; Diabetes Mellitus, Type 2; Gentamicins; Humans; Male; Middle Aged; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium | 2002 |
Diagnosis of Actinobacillus actinomycetemcomitans infective endocarditis after steadily negative blood cultures.
Topics: Actinobacillus Infections; Adult; Aggregatibacter actinomycetemcomitans; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans | 2002 |
Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Child; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; United States | 2002 |
Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia.
Topics: Animals; Bronchoalveolar Lavage Fluid; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Leukocyte Count; Liposomes; Male; Neutrophils; Pneumonia, Pneumococcal; Rats; Rats, Sprague-Dawley; Survival Rate | 2003 |
Results of a prospective, randomized, double blind comparison of the efficacy and the safety of sequential ciprofloxacin (intravenous/oral)+metronidazole (intravenous/oral) with ceftriaxone (intravenous)+metronidazole (intravenous/oral) for the treatment
Topics: Abdominal Abscess; Adult; Aged; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intestinal Perforation; Male; Metronidazole; Middle Aged; Peritonitis; Prospective Studies | 2003 |
[Rupture of the Achilles' tendon secondary to levofloxacin].
Topics: Achilles Tendon; Adult; Ceftriaxone; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Humans; Intestinal Perforation; Levofloxacin; Male; Methylprednisolone; Metronidazole; Ofloxacin; Rupture; Tendinopathy | 2003 |
Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Retrospective Studies | 2002 |
Antibiotic susceptibility of Neisseria gonorrhoeae in Riyadh, Saudi Arabia.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria; Penicillin Resistance; Penicillins; Saudi Arabia; Tetracyclines | 2003 |
Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prostatitis; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Urinalysis | 2003 |
Alarming increase in ciprofloxacin- and penicillin-resistant Neisseria gonorrhoeae isolates in New Delhi, India.
Topics: Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; India; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 2003 |
Molecular epidemiology of endemic ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ceftriaxone; Ciprofloxacin; DNA Fingerprinting; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; England; Female; Gonorrhea; Humans; Male; Medical History Taking; Microbial Sensitivity Tests; Molecular Epidemiology; Neisseria gonorrhoeae; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serotyping | 2003 |
Biotypes and antimicrobial susceptibilities of Brucella isolates.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Brucella melitensis; Brucellosis; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Rifampin; Sensitivity and Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey | 2003 |
High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Cuba; Female; Genotype; Gonorrhea; Humans; Incidence; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Retrospective Studies; Serotyping; Spectinomycin; Tetracycline; Tetracycline Resistance; Urban Population | 2003 |
Non-penicillinase producing Neisseria gonnorhoeae: are they still in existence in Ibadan, Nigeria?
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Anti-Infective Agents; Case-Control Studies; Ceftriaxone; Child; Ciprofloxacin; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Nigeria; Penicillin Resistance; Penicillinase; Prevalence; Sex Distribution; Spectinomycin | 2001 |
[Resistance of Neisseria gonorrhoeae to 4 antibiotics: an analysis of the situation in Guangzhou in 2002].
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin; Tetracycline | 2003 |
Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996-2001.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Spectinomycin | 2003 |
[Diagnosis and treatment of gonorrhea in Copenhagen and Frederiksberg].
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Denmark; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Penicillins; Practice Patterns, Physicians' | 2003 |
Sternoclavicular joint infection in an adult without predisposing risk factors.
Topics: Arthritis, Infectious; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Staphylococcal Infections; Sternoclavicular Joint; Teicoplanin | 2003 |
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Topics: Anti-Bacterial Agents; Argentina; Ceftriaxone; Child; Ciprofloxacin; Humans; Neoplasms; Neutropenia; Outpatients; Randomized Controlled Trials as Topic; Research Design | 2004 |
Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin.
Topics: Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Salmonella enterica; Salmonella Infections; Sepsis; Serotyping | 2004 |
Drug resistance of Shigella species: changes over 20 years in Turkey.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biological Evolution; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Gentamicins; Humans; Shigella; Turkey | 2004 |
Cardiobacterium hominis endocarditis associated with very severe thrombocytopenia and platelet autoantibodies.
Topics: Ampicillin; Antigens, Human Platelet; Aortic Valve Stenosis; Autoantibodies; Autoimmune Diseases; Bacteremia; Bone Marrow; Cardiobacterium; Ceftriaxone; Ciprofloxacin; Diagnostic Errors; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Heart Valve Prosthesis; Histiocytosis, Non-Langerhans-Cell; Humans; Jehovah's Witnesses; Male; Middle Aged; Platelet Transfusion; Postoperative Complications; Purpura, Thrombocytopenic; Splenic Infarction; Thrombocytopenia; Treatment Refusal | 2004 |
Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
Topics: Anti-Infective Agents; Bacteriophage Typing; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; India; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 2004 |
["Actinobacillus and Haemophilus parainfluenzae infective endocarditis: two case reports"].
Topics: Actinobacillus Infections; Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Follow-Up Studies; Haemophilus Infections; Haemophilus parainfluenzae; Humans; Male; Middle Aged; Pleural Effusion; Rifampin; Time Factors; Treatment Outcome | 2004 |
Occurrence of ceftriaxone resistance in ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates causing recurrent infection.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Female; Humans; Middle Aged; Salmonella enterica; Salmonella Infections; Serotyping | 2005 |
A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Salmonella; Salmonella Infections; Taiwan | 2005 |
Metallo-beta-lactamase producing Pseudomonas aeruginosa in a hospital from a rural area.
Topics: Amikacin; beta-Lactamases; Ceftazidime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Gentamicins; Hospitals, Rural; Imipenem; India; Pseudomonas aeruginosa; Species Specificity | 2005 |
Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon.
Topics: Adult; Anti-Bacterial Agents; Cameroon; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella typhi; Treatment Failure; Typhoid Fever | 2005 |
Pneumococcal meningitis and etanercept--chance or association?
Topics: Antirheumatic Agents; Ceftriaxone; Ciprofloxacin; Disease Susceptibility; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infusions, Intravenous; Meningitis, Pneumococcal; Middle Aged; Otitis Media; Receptors, Tumor Necrosis Factor; Streptococcus pneumoniae; Treatment Outcome | 2005 |
Optimizing treatment of antimicrobial-resistant Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Computer Simulation; Cost-Benefit Analysis; Decision Trees; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Monte Carlo Method; Neisseria gonorrhoeae | 2005 |
Comparison of disc diffusion results with minimum inhibitory concentration (MIC) values for antimicrobial susceptibility testing of Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2005 |
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Ceftriaxone; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperglycemia; Hypoglycemia; Levofloxacin; Male; Middle Aged; Ofloxacin; Product Surveillance, Postmarketing; Retrospective Studies | 2005 |
A pilot study on antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Nepal.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Nepal; Penicillins; Pilot Projects; Spectinomycin; Tetracycline | 2005 |
Ciprofloxacin-resistant Salmonella enterica serotype typhi in a patient with osteomyelitis of the rib.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Male; Osteomyelitis; Ribs; Salmonella typhi; Typhoid Fever | 2005 |
[Salmonella prosthetic knee septic arthritis successful retention of the prosthesis with prolonged suppressive therapy].
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Debridement; Drainage; Drug Therapy, Combination; Female; Humans; Knee Joint; Knee Prosthesis; Salmonella enteritidis; Salmonella Infections; Treatment Outcome | 2006 |
Ceftriaxone-resistant Salmonella septicemia and osteomyelitis in sickle cell disease adults.
Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Comorbidity; Humans; Magnetic Resonance Imaging; Male; Osteomyelitis; Psoas Abscess; Salmonella Infections; Salmonella paratyphi C; Sepsis | 2006 |
Bacteraemic pneumonia caused by Neisseria lactamica with reduced susceptibility to penicillin and ciprofloxacin in an adult with liver cirrhosis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Base Sequence; Ceftriaxone; Ciprofloxacin; Humans; Injections, Intravenous; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Neisseria lactamica; Penicillins; Pneumonia, Bacterial; RNA, Bacterial; RNA, Ribosomal, 16S | 2006 |
Fulminant hepatic failure caused by Salmonella paratyphi A infection.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Dexamethasone; Glucocorticoids; Humans; Liver Failure, Acute; Male; Paratyphoid Fever; Salmonella paratyphi A | 2006 |
Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Topics: Adolescent; Age Factors; Amikacin; Ampicillin; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Female; Gentamicins; Humans; Infant; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Nitrofurantoin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections | 2006 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Paratyphoid Fever; Salmonella paratyphi A; Treatment Failure | 2007 |
Diffuse lamellar keratitis associated with gonococcal keratoconjunctivitis 3 years after laser in situ keratomileusis.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Corneal Stroma; Doxycycline; Drug Therapy, Combination; Eye Infections, Bacterial; Gonorrhea; Humans; Keratitis; Keratoconjunctivitis; Keratomileusis, Laser In Situ; Male; Neisseria gonorrhoeae; Surgical Flaps | 2007 |
[Streptococcus pneumoniae cellulitis in a diabetic patient].
Topics: Aged; Ceftriaxone; Cellulitis; Ciprofloxacin; Diabetes Complications; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2007 |
Nonserogroup O1 Vibrio cholerae in a renal transplant patient.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Cholera; Ciprofloxacin; Humans; Kidney Transplantation; Male; Piperacillin; Reoperation; Treatment Outcome; Vibrio cholerae O1 | 2007 |
Prospective study of risk factors for ventilator-associated pneumonia caused by Acinetobacter species.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Female; Humans; Incidence; Intensive Care Units; Logistic Models; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Risk Factors | 2007 |
Ventilator-associated pneumonia by multidrug-resistant bacteria: pathogen-specific risks versus care-related risks.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Incidence; Intensive Care Units; Logistic Models; Pneumonia, Ventilator-Associated; Risk Factors | 2007 |
Travel-acquired salmonellosis due to Salmonella Kentucky resistant to ciprofloxacin, ceftriaxone and co-trimoxazole and associated with treatment failure.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Salmonella enterica; Salmonella Infections; Serotyping; Travel; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Drug-resistant nontyphoidal Salmonella bacteremia, Thailand.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Pilot Projects; Salmonella enterica; Salmonella Infections; Sentinel Surveillance; Thailand | 2007 |
Multidrug-induced erythema multiforme.
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Hypersensitivity; Erythema Multiforme; Female; Humans; Levofloxacin; Methenamine; Ofloxacin; Piroxicam; Skin Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Gas-forming splenic abscess due to Salmonella enterica serotype Enteritidis in a chronically hemodialyzed patient.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Humans; Male; Middle Aged; Renal Dialysis; Salmonella enteritidis; Salmonella Infections; Splenectomy; Splenic Diseases | 2007 |
Multiorgan involvement due to Salmonella typhi: case report.
Topics: Arthritis; Ceftriaxone; Child; Ciprofloxacin; Humans; Male; Osteomyelitis; Salmonella typhi; Typhoid Fever | 2006 |
Endocarditis due to Salmonella enterica subsp. arizonae in a patient with sickle cell disease: a case report and review of the literature.
Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Echocardiography; Endocarditis, Bacterial; Female; Humans; Immunocompromised Host; Kidney Function Tests; Middle Aged; Salmonella arizonae | 2007 |
[Listeriosis in the adult].
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Humans; Listeriosis; Male; Middle Aged; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Salmonella gas-forming femoral osteomyelitis and pyomyositis: the first case and review of the literature.
Topics: Acinetobacter Infections; Ceftriaxone; Ciprofloxacin; Clindamycin; Cross Infection; Fatal Outcome; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Osteomyelitis; Pyomyositis; Salmonella Infections | 2007 |
Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Japan; Male; Microbial Sensitivity Tests; Mouth; Neisseria; Penicillins; Tetracycline | 2007 |
Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.
Topics: Anti-Bacterial Agents; Azithromycin; Bangladesh; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Humans; Microbial Sensitivity Tests; Sentinel Surveillance; Shigella; Species Specificity; Treatment Outcome | 2007 |
The detection of urethritis pathogens among patients with the male urethritis syndrome, genital ulcer syndrome and HIV voluntary counselling and testing clients: should South Africa's syndromic management approach be revised?
Topics: Ceftriaxone; Ciprofloxacin; Counseling; Drug Resistance, Microbial; Gonorrhea; HIV Infections; Humans; Male; Mycoplasma Infections; Patient Acceptance of Health Care; Prospective Studies; South Africa; Syndrome; Trichomonas Infections; Urethritis | 2008 |
Emphysematous cystitis in a asymptomatic haemodialysis patient.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Cystitis; Emphysema; Female; Humans; Incidental Findings; Kidney Failure, Chronic; Klebsiella pneumoniae; Middle Aged; Renal Dialysis; Tomography, X-Ray Computed; Treatment Outcome; Urinary Bladder; Urine | 2008 |
[A sexually transmitted peritonitis].
Topics: Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Female; Gonorrhea; Humans; Middle Aged; Peritonitis; Sexually Transmitted Diseases, Bacterial | 2008 |
In brief: Meningococcal prophylaxis.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Meningococcal Infections; Meningococcal Vaccines; Minnesota; Neisseria meningitidis; North Dakota; Rifampin | 2008 |
Acute bacterial meningitis after transrectal needle biopsy of the prostate: a case report.
Topics: Acute Disease; Aged; Antibiotic Prophylaxis; Biopsy, Needle; Ceftriaxone; Ciprofloxacin; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Bacterial; Escherichia coli; Humans; Male; Meningitis, Escherichia coli; Prostate; Rectum; Urinary Tract Infections | 2008 |
Infectious causes of macrophage activation syndrome.
Topics: Adolescent; Anti-Infective Agents; Bone Marrow; Ceftriaxone; Ciprofloxacin; Female; Fever; Humans; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation; Male; Middle Aged; Risk Factors; Salmonella Infections; Salmonella typhi | 2007 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Alternatives to ciprofloxacin use for enteric Fever, United kingdom.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever; United Kingdom | 2008 |
Chest wall mass caused by salmonella enteritidis - a pitfall of PET imaging interpretation.
Topics: Aged; Anti-Infective Agents; Breast Neoplasms; Ceftriaxone; Ciprofloxacin; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Salmonella enteritidis; Salmonella Infections; Thoracic Diseases; Thoracic Wall; Tomography, X-Ray Computed | 2008 |
Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; HIV Seropositivity; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Prevalence; South Africa; Urethritis | 2008 |
[Acute myocarditis after visiting Pakistan].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents; C-Reactive Protein; Ceftriaxone; Ciprofloxacin; Female; Humans; Myocarditis; Pakistan; Pulmonary Edema; Recurrence; Salmonella typhi; Travel; Treatment Outcome; Typhoid Fever | 2008 |
[A case of Salmonella paratyphi A infection in Poland].
Topics: Adult; Amoxicillin; Ceftriaxone; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Humans; Male; Paratyphoid Fever; Salmonella paratyphi A; Sulfamethizole; Travel; Trimethoprim | 2008 |
Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in 2004-2006 in Bangui, Central African Republic; Yaoundé, Cameroon; Antananarivo, Madagascar; and Ho Chi Minh Ville and Nha Trang, Vietnam.
Topics: Adult; Anti-Bacterial Agents; Cameroon; Ceftriaxone; Central African Republic; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Madagascar; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillinase; Spectinomycin; Vietnam | 2008 |
Evaluation of antibiotic sensitivity pattern in cases of enteric fever in north west Rajasthan.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; In Vitro Techniques; India; Male; Microbial Sensitivity Tests; Middle Aged; Typhoid Fever; Young Adult | 2008 |
[Two cases of Bacillus infection and immunodepression].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacillus; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Male; Middle Aged; Sepsis; Shock, Septic; Treatment Outcome | 2008 |
[Bacterial diarrheas and antibiotics: European recommendations].
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Campylobacter Infections; Campylobacter jejuni; Ceftriaxone; Child; Ciprofloxacin; Diarrhea; Dysentery, Bacillary; Escherichia coli Infections; Gastroenteritis; Humans; Salmonella Infections | 2008 |
[Acute group A beta-hemolytic streptococcus membranous laryngotracheobronchitis in an adult].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Bronchitis; Ceftriaxone; Ciprofloxacin; Croup; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Laryngitis; Laryngoscopy; Methylprednisolone; Middle Aged; Streptococcal Infections; Streptococcus pyogenes; Time Factors; Tracheitis; Treatment Outcome | 2008 |
Study of antibiotic resistance by efflux in clinical isolates of Pseudomonas aeruginosa.
Topics: Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Ethidium; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 2007 |
The trials of the returning traveler: ciprofloxacin failure in enteric fever.
Topics: Adult; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; India; Male; Microbial Sensitivity Tests; Paratyphoid Fever; Recurrence; Salmonella paratyphi A; Travel | 2008 |
Cryptococcal meningoradiculitis: an atypical presentation after initiation of antiretroviral therapy.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Retroviral Agents; Ceftriaxone; Ciprofloxacin; Female; HIV Infections; Humans; Lamivudine; Meningitis, Cryptococcal; Nevirapine; Radiculopathy; Stavudine | 2007 |
[Non necrotizing bacterial cellulitis and bacteriemia due to Shewanella putrefaciens].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Cellulitis; Ciprofloxacin; Dermatologic Agents; Drug Therapy, Combination; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Male; Mycophenolic Acid; Pemphigoid, Bullous; Shewanella putrefaciens; Time Factors; Treatment Outcome | 2009 |
High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoid Salmonella clinical isolates in Asia.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Salmonella; Serotyping | 2009 |
Childhood delayed septic arthritis of the knee caused by Serratia fonticola.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Crataegus; Drainage; Drug Therapy, Combination; Humans; Knee Injuries; Male; Microbial Sensitivity Tests; Serratia Infections; Synovial Fluid | 2009 |
[Treatment's problem of osteoarticular infections in Madagascar].
Topics: Adult; Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Developing Countries; Drug Therapy, Combination; Humans; Madagascar; Osteitis; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2009 |
Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Paris; Penicillin G; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Sexual Behavior; Spectinomycin; Tetracycline; Time Factors; Young Adult | 2009 |
Prevalence of intestinal parasitic and bacterial pathogens in diarrhoeal and non-diarroeal human stools from Vhembe district, South Africa.
Topics: Adult; Animals; Anti-Infective Agents; Bacteria; Ceftriaxone; Child; Ciprofloxacin; Cross-Sectional Studies; Diarrhea; Drug Resistance; Feces; Humans; Intestinal Diseases; Intestinal Diseases, Parasitic; Intestines; Parasites; Prevalence; South Africa | 2009 |
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Synergism; Gentamicins; Lipoglycopeptides; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rifampin; Thienamycins; Time Factors | 2010 |
Drug resistance patterns in Salmonella enterica subspecies enterica serotype Typhi strains isolated over a period of two decades, with special reference to ciprofloxacin and ceftriaxone.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftriaxone; Ciprofloxacin; Cluster Analysis; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Hospitals; Humans; India; Microbial Sensitivity Tests; Restriction Mapping; Salmonella typhi; Typhoid Fever | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
[A case of Salmonella enterica serovar typhi with decreased susceptibility to ciprofloxacin].
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Ofloxacin; Randomized Controlled Trials as Topic; Recurrence; Salmonella paratyphi A; Salmonella typhi; Travel; Typhoid Fever | 2010 |
Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009.
Topics: Anti-Bacterial Agents; Bacteriophage Typing; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella Infections; Salmonella typhimurium; Slovakia | 2010 |
Bacteraemia with pleural effusions complicating typhoid fever caused by high-level ciprofloxacin-resistant Salmonella enterica serotype Typhi.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Ceftriaxone; Child; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drainage; Drug Resistance, Bacterial; Female; Humans; Microbial Sensitivity Tests; Mutation, Missense; Pleural Effusion; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2010 |
Response: A case of massive gastrointestinal haemorrhage (ANZ J. Surg. 2010: 80; 190-1).
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Early Diagnosis; Gastrointestinal Hemorrhage; Humans; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2010 |
[Acral pustules as the key manifestation in the diagnosis of subacute infective endocarditis].
Topics: Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Aortic Valve; Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Edema; Endocarditis, Subacute Bacterial; Fingers; Gentamicins; Hand Dermatoses; Heart Valve Prosthesis; Hemorrhage; Humans; Male; Middle Aged; Nail Diseases; Rheumatic Heart Disease; Ultrasonography | 2010 |
Pleural effusion in an immunocompetent woman caused by Mycobacterium fortuitum.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Female; Humans; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Pleural Effusion; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Carbapenems; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatitis; Retrospective Studies; Vancomycin | 2012 |
Septic arthritis of the ankle due to Salmonella enteritidis.
Topics: Aged; Ankle Joint; Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Humans; Male; Salmonella enteritidis; Salmonella Infections | 2011 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroparesis; Gastroscopy; Humans; Imipenem; Klebsiella oxytoca; Male; Ofloxacin; Pneumonia; Tomography, X-Ray Computed | 2011 |
[Streptococcus pneumonia infection and positive blood culture with Francisella tularensis, in a renal transplant recipient].
Topics: Aged; Anti-Bacterial Agents; Bacteriological Techniques; Blood; Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Francisella tularensis; Gentamicins; Humans; Immunocompromised Host; Kidney Transplantation; Male; Pneumococcal Infections; Tularemia | 2011 |
Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Spectinomycin; Tetracycline; Urban Population | 2011 |
Prostatic abscess a diagnostic dilemma.
Topics: Abscess; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Diagnosis, Differential; Dysuria; Humans; Male; Middle Aged; Prostate; Prostatic Diseases; Ultrasonography; Urinary Retention | 2010 |
Augmentation of antimicrobial activity of conventional antibiotics by cell-free extract of L. plantarum.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Synergism; Lactobacillus plantarum; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Probiotics; Salmonella typhimurium | 2011 |
Epididymo-orchitis: an unusual manifestation of salmonellosis.
Topics: Abscess; Administration, Intravenous; Administration, Oral; Ceftriaxone; Ciprofloxacin; Developing Countries; Epididymitis; Humans; India; Male; Middle Aged; Ofloxacin; Orchitis; Salmonella Infections; Salmonella paratyphi A; Treatment Outcome | 2012 |
Sternoclavicular joint septic arthritis and osteomyelitis caused by Aggregatibacter aphrophilus.
Topics: Aggregatibacter aphrophilus; Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Humans; Image-Guided Biopsy; Middle Aged; Osteomyelitis; Pasteurellaceae Infections; Sternoclavicular Joint; Treatment Outcome; Ultrasonography | 2014 |
In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010.
Topics: Ceftriaxone; Cephalosporin Resistance; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Population Surveillance; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Urinary Tract Infections | 2012 |
Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Ceftriaxone; Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Prospective Studies; Prostatic Neoplasms; Thailand; Ultrasonography, Interventional; Urinary Tract Infections | 2012 |
Meningitis and pneumonitis caused by pet rodents.
Topics: Adult; Animals; Anti-Bacterial Agents; C-Reactive Protein; Ceftriaxone; Ciprofloxacin; Female; Fusobacterium Infections; Humans; Hypoxia; Meningitis, Bacterial; Penicillanic Acid; Pets; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Rats; Respiratory Distress Syndrome; Streptobacillus; Thrombocytopenia | 2012 |
Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not.
Topics: Adaptive Immunity; Administration, Oral; Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Diarrhea; Disease Models, Animal; Drug Administration Schedule; Feces; Infusions, Parenteral; Mice; Mice, Inbred C57BL; Salmonella Infections; Salmonella typhimurium; Severity of Illness Index | 2012 |
Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Ceftriaxone; Ciprofloxacin; Cross Infection; Diagnosis-Related Groups; Drug and Narcotic Control; Drug Prescriptions; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Public; Hospitals, University; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Superinfection; Uruguay | 2011 |
[A rare cause of pneumonia: Shewanella putrefaciens].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bronchiectasis; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Shewanella putrefaciens; Sputum | 2012 |
A 60-year-old man from the highlands of Peru with fever and hemolysis.
Topics: Anemia; Bartonella bacilliformis; Bartonella Infections; Ceftriaxone; Ciprofloxacin; Fever; Hemolysis; Humans; Male; Middle Aged; Peru; Treatment Outcome | 2012 |
Bacteriological agents of chronic discharging ears and their antibiotic sensitivity pattern in Ido - Ekiti, Nigeria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Infant; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Nigeria; Otitis Media, Suppurative; Prospective Studies; Proteus; Pseudomonas; Staphylococcus aureus; Young Adult | 2012 |
Quantitative PCR and in vivo efficacy of antibiotics in the treatment of Vibrio vulnificus infection in a mouse model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bacteriological Techniques; Blood; Ceftriaxone; Ciprofloxacin; Disease Models, Animal; Doxycycline; Drug Monitoring; Drug Therapy, Combination; Male; Mice; Real-Time Polymerase Chain Reaction; Survival Analysis; Treatment Outcome; Vibrio Infections; Vibrio vulnificus | 2012 |
Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriax
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Health Planning Guidelines; Humans; Latin America; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Assurance, Health Care; Retrospective Studies; Sentinel Surveillance; Surveys and Questionnaires | 2012 |
Enteric fever in Cambodian children is dominated by multidrug-resistant H58 Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin.
Topics: Adult; Age Distribution; Anti-Infective Agents; Azithromycin; Cambodia; Ceftriaxone; Child; Child Mortality; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Haplotypes; Hospitals, Pediatric; Humans; Male; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Retrospective Studies; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2012 |
Failure of oral antibiotic therapy, including azithromycin, in the treatment of a recurrent breast abscess caused by Salmonella enterica serotype Paratyphi A.
Topics: Abscess; Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Breast Diseases; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Infusions, Intravenous; Paratyphoid Fever; Recurrence; Salmonella paratyphi A; Suction; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae; Female; Humans; Incidence; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organizational Policy; Time Factors | 2013 |
Characterization of Salmonella food isolates with concurrent resistance to ceftriaxone and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftriaxone; China; Ciprofloxacin; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Food Contamination; Humans; Meat; Microbial Sensitivity Tests; Mutation; Plasmids; Salmonella; Salmonella Food Poisoning; Swine; Swine Diseases | 2013 |
Primary meningococcal arthritis requiring surgical drainage.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxacin; Debridement; Doxycycline; Drainage; Drug Therapy, Combination; Humans; Male; Meningococcal Infections; Neisseria meningitidis; Range of Motion, Articular; Shoulder Joint; Synovial Fluid | 2013 |
Invasive non-typhoidal salmonella infection with multifocal seeding in an immunocompetent host: an emerging disease in the developed world.
Topics: Abscess; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Communicable Diseases, Emerging; Diagnosis, Differential; Humans; Immunocompromised Host; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Pneumonia, Bacterial; Sacroiliitis; Salmonella enteritidis; Salmonella Infections; Young Adult | 2013 |
[Spondylodiscitis associated to Neisseria sicca endocarditis].
Topics: Aged; Anti-Bacterial Agents; Aortic Valve; Ceftriaxone; Ciprofloxacin; Discitis; Endocarditis, Bacterial; Humans; Intervertebral Disc Degeneration; Male; Neisseria sicca; Neisseriaceae Infections; Penicillinase; Thoracic Vertebrae | 2013 |
Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Bacterial; Female; Gonorrhea; Heterosexuality; Homosexuality; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sensitivity and Specificity; Sentinel Surveillance; Tetracycline | 2013 |
Increase in resistance to ceftriaxone and nonsusceptibility to ciprofloxacin and decrease in multidrug resistance among Salmonella strains, United States, 1996-2009.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella; Salmonella Infections; United States; Young Adult | 2013 |
Bacterial isolates from cerebrospinal fluid of children with suspected acute meningitis in a Nigerian tertiary hospital.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cerebrospinal Fluid; Child; Child, Preschool; Ciprofloxacin; Enterococcus; Escherichia coli; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Meningitis, Escherichia coli; Meningitis, Haemophilus; Meningitis, Meningococcal; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Nigeria; Retrospective Studies; Streptococcus agalactiae; Tertiary Care Centers | 2013 |
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) by disk diffusion method.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Coagulase; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Gentamicins; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Suppuration; Surgical Wound Infection; Vancomycin | 2013 |
Antimicrobial susceptibility patterns of Streptococcus pneumoniae over 6 years at Gondar University Hospital, Northwest Ethiopia.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethiopia; Hospitals, University; Humans; Microbial Sensitivity Tests; Retrospective Studies; Streptococcus pneumoniae | 2013 |
Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards.
Topics: Acinetobacter baumannii; Air Microbiology; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burn Units; Carbapenems; Cefoperazone; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Repetitive Sequences, Nucleic Acid; Sulbactam | 2014 |
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; beta-Lactam Resistance; Cefixime; Ceftriaxone; Ciprofloxacin; Epidemiological Monitoring; Female; Gonorrhea; Humans; Incidence; Japan; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillin G | 2013 |
Genetic variations in the active efflux pump genes acrA/B and tolC in different drug-induced strains of Escherichia coli CVCC 1547.
Topics: Amikacin; Bacterial Outer Membrane Proteins; Ceftriaxone; Ciprofloxacin; Codon, Nonsense; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Lipoproteins; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Mutation, Missense; Sequence Analysis, DNA | 2013 |
Fever of unknown origin attributable to haematocolpos infected with Salmonella enterica Serotypetyphi resistant to nalidixic acid: a case report.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Bacterial; Female; Fever of Unknown Origin; Hematocolpos; Humans; Metronidazole; Nalidixic Acid; Salmonella typhi | 2013 |
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Switzerland; Young Adult | 2013 |
Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Female; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Neisseria gonorrhoeae; Penicillins; Saskatchewan; Sequence Analysis, DNA; Spectinomycin; Tetracycline; Young Adult | 2014 |
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Phenotype; Switzerland; Tetracycline; Young Adult | 2014 |
Renal abscess yields elusive hypermucoviscous phenotype of, uropathogenic Escherichia coli: a case report.
Topics: Abscess; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drainage; Escherichia coli Infections; Female; Humans; Kidney Diseases; Middle Aged; Phenotype; Tomography, X-Ray Computed; Urinary Tract; Urinary Tract Infections; Uropathogenic Escherichia coli | 2013 |
Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Salmonella Infections; Salmonella typhimurium | 2014 |
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Promoter Regions, Genetic; Repressor Proteins; RNA, Ribosomal, 23S; Spectinomycin; Treatment Failure | 2014 |
In vitro synergy of ampicillin with gentamicin, ceftriaxone and ciprofloxacin against Enterococcus faecalis.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Drug Synergism; Enterococcus faecalis; Gentamicins; Microbial Sensitivity Tests; Time Factors | 2014 |
Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Neisseria gonorrhoeae; Prevalence; Russia; Spectinomycin; Young Adult | 2014 |
Surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae in Nanning, China, 2000 to 2012.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Azithromycin; beta-Lactamases; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin; Tetracycline | 2014 |
Ceftriaxone Potentiates Warfarin Activity Greater Than Other Antibiotics in the Treatment of Urinary Tract Infections.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Humans; International Normalized Ratio; Penicillins; Retrospective Studies; Urinary Tract Infections; Warfarin | 2016 |
Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Hungary; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline; Time Factors; Young Adult | 2014 |
GC-MS characterisation and antibacterial activity evaluation of Nigella sativa oil against diverse strains of Salmonella.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gas Chromatography-Mass Spectrometry; Microbial Sensitivity Tests; Nigella sativa; Plant Oils; Salmonella | 2015 |
Antibacterial activity of three newly-synthesized chalcones & synergism with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Chalcones; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Ciprofloxacin; Drug Synergism; Gentamicins; Magnetic Resonance Spectroscopy; Mass Spectrometry; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Statistics, Nonparametric; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
[Modalities of management of cancer patients with febrile neutropenia in the oncology emergency unit of Gustave-Roussy and their related costs].
Topics: Adult; Aged; Ambulatory Care; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Agents; Cancer Care Facilities; Ceftriaxone; Ciprofloxacin; Emergency Service, Hospital; Febrile Neutropenia; Female; France; Hospitalization; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Assessment; Young Adult | 2014 |
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance | 2014 |
Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Condoms; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillins; Sexual and Gender Minorities; Taiwan; Unsafe Sex | 2016 |
Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated from Guangzhou, China, 2000 to 2005 and 2008 to 2013.
Topics: Anti-Bacterial Agents; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Spectinomycin | 2015 |
Twenty-five-year changing pattern of gonococcal antimicrobial susceptibility in Shanghai: surveillance and its impact on treatment guidelines.
Topics: Anti-Bacterial Agents; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Prevalence; Spectinomycin; Tetracycline; Tetracycline Resistance | 2014 |
Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Humans; Injections, Intramuscular; Male; Patient Admission; Postoperative Complications; Preoperative Care; Prostate; Retrospective Studies | 2015 |
Editorial comment.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Endoscopic Ultrasound-Guided Fine Needle Aspiration; Humans; Male; Patient Admission; Postoperative Complications; Prostate | 2015 |
Australian Meningococcal Surveillance Programme annual report, 2013.
Topics: Adolescent; Adult; Age Distribution; Aged; Annual Reports as Topic; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Epidemiological Monitoring; Gene Expression; Genotype; Humans; Infant; Meningococcal Infections; Microbial Sensitivity Tests; Middle Aged; Neisseria meningitidis; Penicillins; Phenotype; Porins; Rifampin; Serotyping | 2014 |
Australian gonococcal surveillance programme, 1 April to 30 June 2014.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Disease Notification; Drug Combinations; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2014 |
Trends of resistance to antimicrobials recommended currently and in the past for management of gonorrhea in the Apex STD center in India and comparison of antimicrobial resistance profile between 2002-2006 and 2007-2012.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Health Planning Guidelines; Humans; India; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin | 2015 |
Clinical and microbiological profiles of shigellosis in children.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Feces; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Shigella; Shigella flexneri; Virulence Factors | 2014 |
Prevalence of gonococcal conjunctivitis in adults and neonates.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Conjunctivitis, Bacterial; Eye Infections, Bacterial; Female; Gonorrhea; Hospitals, Maternity; Hospitals, Special; Humans; Ireland; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Ophthalmia Neonatorum; Ophthalmology; Polymerase Chain Reaction; Prevalence; Young Adult | 2015 |
[Experimental substantiation of possibility of sanation for purulent enteritis in mechanical acute ileus].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Ciprofloxacin; Fluoroquinolones; Gentamicins; Ileitis; Ileum; Ileus; Injections, Intramuscular; Microbial Sensitivity Tests; Rats; Rats, Wistar | 2015 |
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2015 |
Bloodstream bacterial infection among outpatient children with acute febrile illness in north-eastern Tanzania.
Topics: Acute Disease; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Microbial Sensitivity Tests; Microscopy; Outpatients; Plasmodium falciparum; Pneumonia, Pneumococcal; Rural Population; Salmonella typhi; Streptococcus pneumoniae; Tanzania; Typhoid Fever | 2015 |
Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Biopsy; Ceftriaxone; Ciprofloxacin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gentamicins; Humans; Male; Middle Aged; Prostate; Retrospective Studies; Sepsis; Ultrasound, High-Intensity Focused, Transrectal; Urinary Tract Infections | 2015 |
Gardnerella vaginalis: An overlooked pathogen in male patients?
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gardnerella vaginalis; Gram-Positive Bacterial Infections; Humans; Immunocompetence; Male; Metronidazole; Recurrence; Sex Distribution; Urethritis | 2015 |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Gene Expression; Gonorrhea; Humans; Isoxazoles; Male; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds; Tetracycline; Topoisomerase II Inhibitors; Urethritis | 2016 |
An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England.
Topics: Adult; Azithromycin; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Disease Outbreaks; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; England; Female; Gonorrhea; Heterosexuality; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Treatment Outcome | 2016 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Neisseria elongata subsp elongata infective endocarditis following endurance exercise.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Echocardiography; Endocarditis, Bacterial; Female; Humans; Mitral Valve Annuloplasty; Mitral Valve Insufficiency; Neisseria elongata; Neisseriaceae Infections; Physical Endurance; Running; Splenic Infarction; Travel; Uganda; United Kingdom | 2015 |
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin | 2015 |
Characteristics of bacterial acute diarrhea among women.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Brazil; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Diarrhea; Dysentery, Bacillary; Female; Humans; Microbial Sensitivity Tests; Pregnancy; Retrospective Studies; Salmonella; Salmonella Infections; Shigella; Sulfamethoxazole; Trimethoprim; Young Adult | 2016 |
Temocillin in vitro activity against recent clinical isolates of Neisseria gonorrhoeae compared with penicillin, ceftriaxone and ciprofloxacin.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2016 |
Australian Gonococcal Surveillance Programme, 1 April to 30 June 2015.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Epidemiological Monitoring; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2015 |
Increasing Incidence of High-Level Tetracycline-Resistant Neisseria gonorrhoeae due to Clonal Spread and Foreign Import.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Incidence; Microbial Sensitivity Tests; Molecular Epidemiology; Neisseria gonorrhoeae; Republic of Korea; Sequence Analysis, DNA; Tetracycline; Tetracyclines | 2016 |
Septicemia Caused by Neisseria meningitidis With Decreased Ciprofloxacin Susceptibility: The First Case Report in Korea.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Neisseria meningitidis; Polymerase Chain Reaction; Sepsis; Transcription Factors; Young Adult | 2016 |
Ciprofloxacin and ceftriaxone alter cytokine responses, but not Toll-like receptors, to Salmonella infection in vitro.
Topics: Animals; Bacterial Adhesion; Ceftriaxone; Cell Line; Ciprofloxacin; Cytokines; Endocytosis; Host-Pathogen Interactions; Immunologic Factors; Macrophages; Mice; Models, Biological; Salmonella Infections; Salmonella typhimurium; Toll-Like Receptors | 2016 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Probenecid; Public Health Surveillance | 2016 |
Near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy white man: a case report.
Topics: Adult; Bacteremia; Ceftriaxone; Ciprofloxacin; Clindamycin; Coinfection; Edwardsiella tarda; Enterobacteriaceae Infections; Humans; Male; Methicillin; Near Drowning; Oxacillin; Pneumonia; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015).
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Neisseria gonorrhoeae; Oligonucleotide Array Sequence Analysis; Russia; Spectinomycin; Tetracycline | 2016 |
Glycosylated Conductive Polymer: A Multimodal Biointerface for Studying Carbohydrate-Protein Interactions.
Topics: Aniline Compounds; Anti-Bacterial Agents; Biosensing Techniques; Carbohydrates; Ceftriaxone; Ciprofloxacin; Electric Conductivity; Electrochemical Techniques; Glycosylation; Hydrogen-Ion Concentration; Mannosides; Microbial Sensitivity Tests; Oxidation-Reduction; Polymers; Proteins; Tetracycline; Thiophenes | 2016 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Germany, West; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline; Tetracyclines; Treatment Outcome | 2016 |
Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cell Count; Cell Survival; Chloramphenicol; Ciprofloxacin; Gentamicins; Growth Charts; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Theoretical; Neisseria gonorrhoeae; Penicillin G; Spectinomycin; Tetracycline; Time Factors | 2016 |
Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
Topics: Adult; Alleles; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gene Expression; Gonorrhea; Humans; Hungary; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Phylogeny; Porins; Prevalence; Spectinomycin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetracycline; Transferrin-Binding Protein B | 2016 |
Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium Infection.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Escherichia coli; Escherichia coli Proteins; Female; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Plasmids; Polymorphism, Single Nucleotide; Prophages; Salmonella Infections; Salmonella typhimurium; Treatment Failure | 2016 |
Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Liver Cirrhosis; Male; Meropenem; Middle Aged; Peritonitis; Prospective Studies; Streptococcal Infections; Thienamycins | 2017 |
Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes.
Topics: Anti-Bacterial Agents; Australia; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Gonorrhea; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Spectinomycin; Tetracycline Resistance | 2017 |
Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Utilization; Female; Genotyping Techniques; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2017 |
Nanomechanical sensor applied to blood culture pellets: a fast approach to determine the antibiotic susceptibility against agents of bloodstream infections.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Double-Blind Method; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Microscopy, Atomic Force; Nanotechnology | 2017 |
Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010-2011.
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; South America; Tetracycline | 2017 |
Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cervix Uteri; Chi-Square Distribution; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Neisseria gonorrhoeae; Penicillins; Prevalence; Spectinomycin; Tetracycline; Urethra; Young Adult | 2017 |
Synergism in dual functionality of cryptdin-2 in conjunction with antibiotics against
Topics: Animals; Antioxidants; Ceftriaxone; Ciprofloxacin; Defensins; Drug Combinations; Drug Synergism; Humans; Liver; Mice; Microscopy, Electron, Scanning; Nitric Oxide; Proteins; Salmonella Infections; Salmonella typhimurium; Tumor Necrosis Factor-alpha | 2016 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2016
.
Topics: Annual Reports as Topic; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Public Health Surveillance | 2017 |
Pneumonia with pleural empyema caused by Salmonella Typhi in an immunocompetent child living in a non-endemic country.
Topics: Adolescent; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drainage; Empyema, Pleural; Female; France; Humans; Pneumonia, Bacterial; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2018 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |
Antimicrobial susceptibility in
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult; Zimbabwe | 2018 |
Characterization of Clinically Isolated Antibiotic-Resistant Salmonella Typhimurium Exposed to Subinhibitory Concentrations of Ceftriaxone and Ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Salmonella typhimurium | 2017 |
Antibiotics in acute calculous cholecystitis - do Tokyo guidelines influence the surgeons' practices?
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Cholecystectomy; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Ciprofloxacin; Conversion to Open Surgery; Drug Therapy, Combination; Female; Gallstones; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Pakistan; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index; Surgeons; Surgical Wound Infection; Treatment Outcome | 2017 |
Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Contact Tracing; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gonorrhea; Hawaii; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline; Young Adult | 2017 |
Patterns in antimicrobial susceptibility of Salmonellae isolated at a tertiary care hospital in northern India.
Topics: Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Salmonella enterica; Salmonella Infections; Tertiary Care Centers | 2017 |
Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Cost-Benefit Analysis; Drug Resistance, Bacterial; England; Female; Gonorrhea; Humans; Lost to Follow-Up; Male; Microbial Sensitivity Tests; Models, Theoretical; Neisseria gonorrhoeae; Penicillins; Point-of-Care Testing | 2017 |
Trends in antimicrobial resistance in Neisseria gonorrhoeae and molecular characteristics of N. gonorrhoeae with decreased susceptibility to ceftriaxone in Shandong, China, 2007 to 2014.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fimbriae Proteins; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Polymorphism, Single Nucleotide; Repressor Proteins; Tetracycline | 2018 |
Molecular Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae, Northern Territory, Australia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Northern Territory; Penicillins; Public Health Surveillance | 2017 |
Genomic Analysis and Resistance Mechanisms in Shigella flexneri 2a Strain 301.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Computational Biology; DNA, Bacterial; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Gene Ontology; Genes, Bacterial; Genome, Bacterial; Humans; Molecular Sequence Annotation; Phylogeny; Polymorphism, Single Nucleotide; Shigella flexneri; Tetracycline; Whole Genome Sequencing | 2018 |
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Female; Gonorrhea; Heterosexuality; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult | 2017 |
Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Disease Transmission, Infectious; Drug Resistance, Microbial; Gonorrhea; Humans; Microbial Sensitivity Tests; Models, Theoretical; Neisseria gonorrhoeae; Point-of-Care Systems | 2017 |
Automated direct screening for resistance of Gram-negative blood cultures using the BD Kiestra WorkCell.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2018 |
Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Doxycycline; Drug Synergism; Drug Therapy, Combination; Female; Foodborne Diseases; Humans; Mice; Seafood; Sepsis; Vibrio Infections; Vibrio vulnificus | 2017 |
Antimicrobial susceptibility profile of
Topics: Anti-Bacterial Agents; Benin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Urethritis; Uterine Cervicitis | 2018 |
High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Point-of-Care Systems; Retrospective Studies; Saskatchewan; Spectinomycin; Young Adult | 2018 |
Current Trends of Antimicrobial Susceptibility of Typhoidal Salmonellae Isolated at Tertiary Care Hospital.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Humans; Pakistan; Salmonella typhi; Tertiary Care Centers; Typhoid Fever | 2017 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Vientiane, Lao PDR.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Laos; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Young Adult | 2018 |
Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Exanthema; Female; Fever; Humans; Meningococcal Infections; Mutation; Neisseria meningitidis; Serogroup; Vomiting | 2018 |
A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
Topics: Anti-Bacterial Agents; Azithromycin; California; Ceftriaxone; Ciprofloxacin; Costs and Cost Analysis; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Genotyping Techniques; Gonorrhea; Humans; Neisseria gonorrhoeae; Retrospective Studies | 2018 |
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cervix Uteri; Ciprofloxacin; Female; Germany; Gonorrhea; Humans; Laboratories; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Rectum; Urethra; Vagina; Young Adult | 2018 |
Microbial contaminants isolated from items and work surfaces in the post- operative ward at Kawolo general hospital, Uganda.
Topics: Anti-Bacterial Agents; Bedding and Linens; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacteria; Hospitals, General; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Operating Tables; Staphylococcus aureus; Surgical Attire; Surgical Equipment; Uganda; Vancomycin | 2018 |
Reduced Risk of Sepsis after Prostate Biopsy Using a Cephalosporin-Fluoroquinolone Antibiotic Regimen and Isopropyl Alcohol Needle Washing.
Topics: 2-Propanol; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Body Mass Index; Ceftriaxone; Ciprofloxacin; Comorbidity; Diabetes Mellitus, Type 2; Disinfection; Drug Therapy, Combination; Gentamicins; Humans; Incidence; Male; Middle Aged; Needles; Prostate; Random Allocation; Risk Factors; Sepsis | 2018 |
Brought Down by a Mosquito? West Nile Virus Encephalitis.
Topics: Acyclovir; Anti-Infective Agents; Brain; Ceftriaxone; Ciprofloxacin; Consciousness Disorders; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paresis; Vancomycin; West Nile Fever; West Nile virus | 2018 |
Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.
Topics: Adolescent; Adult; Aged; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Infant; Male; Meningitis, Meningococcal; Meningococcal Infections; Meropenem; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multilocus Sequence Typing; Neisseria meningitidis; Neisseria meningitidis, Serogroup B; Neisseriaceae Infections; Prevalence; Republic of Korea; Rifampin; RNA, Ribosomal, 16S; Serogroup | 2018 |
First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015-16.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Brazil; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult | 2018 |
Quality assurance for antimicrobial susceptibility testing of
Topics: Anti-Bacterial Agents; Azithromycin; Caribbean Region; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Epidemiological Monitoring; Gonorrhea; Humans; Laboratories, Hospital; Laboratory Proficiency Testing; Latin America; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quality Control; Reproducibility of Results | 2018 |
Phenotypical resistance correlation networks for 10 non-typhoidal Salmonella subpopulations in an active antimicrobial surveillance programme.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Linear Models; Meat; Phenotype; Salmonella enterica; Salmonella Infections, Animal; Selection, Genetic; United States | 2018 |
Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
Topics: Adolescent; Ampicillin; Anti-Infective Agents; Brazil; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Humans; Infant; Male; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Rifampin | 2018 |
Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Female; Genotype; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny; Public Health Surveillance; Whole Genome Sequencing; Young Adult | 2018 |
Transfer of a gonococcal β-lactamase plasmid into Neisseria gonorrhoeae belonging to the globally distributed ST1407 lineage.
Topics: beta-Lactamases; Cefixime; Ceftriaxone; Ciprofloxacin; Gene Transfer, Horizontal; Genotype; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Plasmids | 2018 |
Molecular screening for Neisseria gonorrhoeae antimicrobial resistance markers in Nigerian men who have sex with men and transgender women.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Nigeria; Nucleic Acid Amplification Techniques; Penicillins; Real-Time Polymerase Chain Reaction; Transgender Persons; Young Adult | 2018 |
Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoeae isolates from men who have sex with men.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Repressor Proteins; Sequence Analysis, DNA; Spectinomycin; Tetracycline | 2019 |
Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Kenya; Microbial Sensitivity Tests; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2018 |
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Europe; Female; Gentamicins; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin; Young Adult | 2018 |
Comparative Activity of Ceftriaxone, Ciprofloxacin, and Gentamicin as a Function of Bacterial Growth Rate Probed by Escherichia coli Chromosome Replication in the Mouse Peritonitis Model.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Gentamicins; Mice; Peritonitis | 2019 |
Comparison of Neisseria gonorrhoeae minimum inhibitory concentrations obtained using agar dilution versus microbroth dilution methods.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Colony Count, Microbial; Culture Media; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Tetracycline | 2019 |
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report.
Topics: Aged; Anti-Bacterial Agents; Antibody Specificity; Antifungal Agents; Autoantibodies; Autoimmune Diseases; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Substitution; Drug Therapy, Combination; Factor V; Factor V Deficiency; Fluoroquinolones; Humans; Levofloxacin; Male; Meropenem; Micafungin; Partial Thromboplastin Time; Pneumonia; Prothrombin Time | 2019 |
Salmonella Typhimurium and Salmonella Enteritidis Infections in Sporadic Diarrhea in Children: Source Tracing and Resistance to Third-Generation Cephalosporins and Ciprofloxacin.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child Health Services; Child, Preschool; China; Ciprofloxacin; Contact Tracing; Diarrhea, Infantile; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Food Microbiology; Humans; Infant; Male; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium | 2019 |
Identifying the mechanism underlying treatment failure for Salmonella Paratyphi A infection using next-generation sequencing - a case report.
Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Male; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi A; Treatment Failure | 2019 |
Evolution and transmission of a conjugative plasmid encoding both ciprofloxacin and ceftriaxone resistance in Salmonella.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Meat Products; Mice; Plasmids; Recombination, Genetic; Salmonella; Salmonella Infections; Treatment Failure | 2019 |
Yersinia pseudotuberculosis bacteraemia: a diagnostic dilemma in the era of MALDI-TOF mass spectrometry.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Bacteriophages; Ceftriaxone; Ciprofloxacin; Diagnosis, Differential; Female; Humans; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections | 2019 |
Australian Gonococcal Surveillance Programme, 1 July to 30 September 2018
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Public Health Surveillance | 2019 |
[From surveillance to action: Modifying therapeutic behaviours in gonococcal infections].
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Controlled Before-After Studies; Doxycycline; Female; Gonorrhea; Humans; Incidence; Male; Medication Adherence; Microbiology; Middle Aged; Neisseria gonorrhoeae; Physicians, Primary Care; Population Surveillance; Quinolones; Spain; Young Adult | 2020 |
Current antibiotic use in the treatment of enteric fever in children.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Humans; India; Male; Microbial Sensitivity Tests; Salmonella enterica; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2019 |
Trends and Risk Factors for Antimicrobial-Resistant
Topics: Adult; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neisseria gonorrhoeae; Risk Factors; Young Adult | 2019 |
Agent-based modelling study of antimicrobial-resistant Neisseria gonorrhoeae transmission in men who have sex with men: towards individualised diagnosis and treatment.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Homosexuality, Male; Humans; London; Male; Models, Statistical; Neisseria gonorrhoeae; Point-of-Care Testing | 2019 |
Historical contingency in the evolution of antibiotic resistance after decades of relaxed selection.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Directed Molecular Evolution; Drug Resistance, Bacterial; Escherichia coli; Genotype; Mutation; Public Health; Quantitative Trait, Heritable; Selection, Genetic; Tetracycline | 2019 |
Susceptibility patterns in
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Greenland; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2019 |
Factors associated with Salmonella infection in patients with gastrointestinal complaints seeking health care at Regional Hospital in Southern Highland of Tanzania.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Female; Gastrointestinal Diseases; Hospitals; Humans; Infant; Male; Middle Aged; Prevalence; Salmonella; Salmonella Infections; Tanzania; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever; Young Adult | 2020 |
Antibiotic resistance patterns and prevalence of class I, II and III Integrons among clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Cefepime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Guidelines as Topic; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Male; Polymerase Chain Reaction; Pseudomonas aeruginosa; Streptomycin | 2020 |
Australian Meningococcal Surveillance Programme annual report, 2018.
Topics: Adult; Age Distribution; Anti-Bacterial Agents; Australia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; Humans; Infant; Male; Meningococcal Infections; Middle Aged; Neisseria meningitidis; Penicillins; Population Surveillance; Serogroup | 2020 |
Non-typhoidal Salmonella bloodstream infections in Kisantu, DR Congo: Emergence of O5-negative Salmonella Typhimurium and extensive drug resistance.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Congo; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Salmonella; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium; Serogroup; Typhoid Fever; Young Adult | 2020 |
Isolated splenic abscess due to
Topics: Abdominal Abscess; Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Male; Salmonella Infections; Splenic Diseases | 2020 |
Emerging coexistence of three PMQR genes on a multiple resistance plasmid with a new surrounding genetic structure of qnrS2 in E. coli in China.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Genome Size; Levofloxacin; Microbial Sensitivity Tests; Mutation; Plasmids; Whole Genome Sequencing | 2020 |
Francisella tularensis as the cause of protracted fever.
Topics: Abdominal Pain; Anti-Bacterial Agents; Body Weight; Ceftriaxone; Ciprofloxacin; Cough; Diagnosis, Differential; Diarrhea; Doxycycline; Farmers; Fever; Francisella tularensis; Humans; Male; Middle Aged; Serologic Tests; Tularemia | 2020 |
Antimicrobial sensitivity profile and bacterial isolates among suspected pyogenic meningitis patients attending at Hawassa University Hospital: Cross-sectional study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Infant; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Penicillins; Phylogeny; Young Adult | 2020 |
Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Demography; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin G; Population Surveillance; Sentinel Surveillance; Spectinomycin; Tetracycline; Uganda | 2020 |
Bacterial Profile, Antimicrobial Susceptibility Pattern, and Associated Risk Factors Among Patients With Wound Infections at Debre Markos Referral Hospital, Northwest, Ethiopia.
Topics: Agar; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Gentamicins; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Referral and Consultation; Risk Factors; Staphylococcus aureus; Wound Infection | 2022 |
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Virulence Factors | 2020 |
Australian Gonococcal Surveillance Programme Annual Report, 2019.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; History, 21st Century; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; New South Wales; Northern Territory; Penicillin Resistance; Penicillins; Population Surveillance; Queensland; Tasmania; Victoria; Western Australia | 2020 |
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Germany; Gonorrhea; Humans; Laboratories; Laboratory Proficiency Testing; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quality Control; Reference Standards; Surveys and Questionnaires | 2020 |
Australian Meningococcal Surveillance Programme annual report, 2019.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Australia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; History, 21st Century; Humans; Infant; Male; Meningococcal Infections; Microbial Sensitivity Tests; Middle Aged; Neisseria meningitidis; Penicillins; Public Health Surveillance; Rifampin; Serogroup; Serotyping; Young Adult | 2020 |
Assessment of phage-mediated inhibition of Salmonella Typhimurium treated with sublethal concentrations of ceftriaxone and ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacteriophages; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Salmonella typhimurium | 2020 |
Controlled release of ciprofloxacin and ceftriaxone from a single ototopical administration of antibiotic-loaded polymer microspheres and thermoresponsive gel.
Topics: Acute Disease; Administration, Topical; Animals; Anti-Bacterial Agents; Ceftriaxone; Chinchilla; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Gels; Guinea Pigs; Microspheres; Otitis Media | 2020 |
Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Biofilms; Ceftriaxone; Ciprofloxacin; Combined Modality Therapy; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Fosfomycin; Gentamicins; Meropenem; Microbial Sensitivity Tests; Moths; Phage Therapy; Prosthesis-Related Infections | 2020 |
Australian Gonococcal Surveillance Programme 1 July to 30 September 2020.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Public Health Surveillance | 2020 |
Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Prospective Studies; Sexual and Gender Minorities; Spain | 2021 |
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; European Union; Female; Gonorrhea; Heterosexuality; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sex Factors; Sexual and Gender Minorities; Sexual Behavior | 2021 |
Emergence of Conjugative IncC Type Plasmid Simultaneously Encoding Resistance to Ciprofloxacin, Ceftriaxone, and Azithromycin in Salmonella.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Microbial Sensitivity Tests; Plasmids; Salmonella | 2021 |
Developing a model to predict individualised treatment for gonorrhoea: a modelling study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; England; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities; Wales | 2021 |
Molecular characterization of a ceftriaxone-resistant Neisseria gonorrhoeae strain found in Switzerland: a case report.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Ceftriaxone; Ciprofloxacin; DNA, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Phenotype; Polymerase Chain Reaction; Switzerland | 2021 |
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; Ertapenem; Gentamicins; Gonorrhea; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Neisseria gonorrhoeae | 2021 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Infant; Jamaica; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2021 |
Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Gonorrhea; Humans; Malawi; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Polymorphism, Single Nucleotide; Spectinomycin; Tetracycline; Treatment Outcome | 2022 |
Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; England; Humans; Meningitis, Meningococcal; Neisseria meningitidis; Northern Ireland; Penicillins; Rifampin; Wales | 2021 |
Dissemination and genome analysis of high-level ceftriaxone-resistant
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; China; Ciprofloxacin; Drug Resistance, Bacterial; Genome, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Spectinomycin | 2022 |
Antimicrobial defined daily dose in neonatal population.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Stewardship; Ceftriaxone; Ciprofloxacin; Humans; Infant; Infant, Newborn | 2022 |
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Laos; Ofloxacin; Prevalence; Sulfamethoxazole; Trimethoprim | 2022 |
Prevalence, antimicrobial resistance and virulence genes of Salmonella serovars isolated from humans and animals.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Prevalence; Salmonella enterica; Serogroup; Tetracyclines; Virulence | 2022 |
First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017-2020.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Mitomycin; Neisseria gonorrhoeae; Qatar; Tetracycline | 2022 |
Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2021 |
Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.
Topics: Ampicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillins; United States | 2022 |
Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftriaxone; Ciprofloxacin; Ertapenem; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Hemolysis; Urinary Tract Infections; Virulence; Virulence Factors | 2022 |
Antimicrobial resistance and genomic relationships of Salmonella enterica from Australian cattle.
Topics: Animals; Anti-Bacterial Agents; Australia; Cattle; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genomics; Microbial Sensitivity Tests; Salmonella; Salmonella enterica | 2022 |
Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Humans; Japan; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillins; Phylogeny | 2022 |
Spectinomycin, gentamicin, and routine disc diffusion testing: An alternative for the treatment and monitoring of multidrug-resistant Neisseria gonorrhoeae?
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Gentamicins; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin | 2022 |
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisseria gonorrhoeae; World Health Organization | 2021 |
Clinical and Genomic Investigation of an International Ceftriaxone- and Azithromycin-Resistant Shigella sonnei Cluster among Men Who Have Sex with Men, Montréal, Canada 2017-2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Dysentery, Bacillary; Genomics; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Phylogeny; Sexual and Gender Minorities; Shigella sonnei | 2022 |
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngitis; Sexual and Gender Minorities | 2022 |
Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Ceftriaxone; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ciprofloxacin; Humans; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry | 2022 |
Resistance-Guided Therapy for Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2022 |
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Peru; Spectinomycin | 2022 |
Phylogenomic Analysis of Salmonella enterica Serovar Indiana ST17, an Emerging Multidrug-Resistant Clone in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Clone Cells; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Phylogeny; Plasmids; Quinolones; Retrospective Studies; Salmonella enterica; Serogroup | 2022 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
An Optimized Checkerboard Method for Phage-Antibiotic Synergy Detection.
Topics: Anti-Bacterial Agents; Bacteriophages; Ceftriaxone; Ciprofloxacin; Drug Synergism; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2022 |
Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sequence Analysis; Spectinomycin; Tetracycline; Thailand | 2022 |
Clinical Features, Antimicrobial Resistance, and Serogroups of Nontyphoidal Salmonella Isolated From Infants Less Than 3 Months Old in the Recent Decade.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Infant; Salmonella; Salmonella Infections; Serogroup; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Antimicrobial resistance of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Urban Hospitals, Lusaka, Zambia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; Hospitals, Urban; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Prospective Studies; Tetracycline; Zambia | 2022 |
Screening of Antibacterial Efficacy of Chitosan Encapsulated Probiotics (Lactococcus lactis and Lactobacillus curvattus) against Clinical Bacterial Pathogens.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Buffaloes; Ceftriaxone; Cephalothin; Cephradine; Chitosan; Chloramphenicol; Ciprofloxacin; Erythromycin; Lactobacillus; Lactococcus lactis; Probiotics; Tetracyclines; Tobramycin | 2022 |
Australian Gonococcal Surveillance Programme Annual Report, 2021.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Neisseria gonorrhoeae; Northern Territory; Penicillins | 2022 |
Trends and regional variations of gonococcal antimicrobial resistance in the Netherlands, 2013 to 2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Netherlands; Sentinel Surveillance; Sexual and Gender Minorities | 2022 |
Clinical profiles and antimicrobial resistance patterns of invasive Salmonella infections in children in China.
Topics: Ampicillin; Anti-Bacterial Agents; C-Reactive Protein; Ceftriaxone; Child; Child, Preschool; China; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Procalcitonin; Salmonella; Salmonella Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2022 |
Right hip gonococcal septic arthritis treatment with successful transition to oral fluoroquinolone.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Levofloxacin; Tetracycline | 2022 |
Aetiology, antimicrobial susceptibility and outcome of children with sepsis, admitted at Muhimbili National Hospital, Dar es Salaam.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Child, Preschool; Ciprofloxacin; Clindamycin; Coagulase; Cross-Sectional Studies; Escherichia coli; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Sepsis; Staphylococcus aureus; Tanzania | 2022 |
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cefixime; Ceftriaxone; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Microbial; Ethiopia; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline | 2022 |
Genotypic Detection of
Topics: Agar; Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Ciprofloxacin; Citrobacter koseri; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Molecular Detection of
Topics: Amikacin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Vancomycin | 2022 |
Copper sulfide and zinc oxide hybrid nanocomposite for wastewater decontamination of pharmaceuticals and pesticides.
Topics: Acetates; Ceftriaxone; Ciprofloxacin; Copper; Decontamination; Ibuprofen; Nanocomposites; Pesticides; Pharmaceutical Preparations; Sulfides; Wastewater; Zinc Oxide | 2022 |
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Ifosfamide; Imipenem; Linezolid; Microbial Sensitivity Tests; Mycetoma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
Transcriptome analysis of sRNA responses to four different antibiotics in Pseudomonas aeruginosa PAO1.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Polymyxin B; Pseudomonas aeruginosa | 2022 |
Oral ciprofloxacin activity against ceftriaxone-resistant Escherichia coli in an in vitro bladder infection model.
Topics: Anti-Bacterial Agents; Bacteria; Ceftriaxone; Ciprofloxacin; Cystitis; Escherichia coli; Humans; Microbial Sensitivity Tests; Urinary Bladder; Urinary Tract Infections | 2023 |
Assessing the National Representativeness of Estimates of Antimicrobial-Resistant Urogenital Neisseria gonorrhoeae in US Men, Gonococcal Isolate Surveillance Project, 2008-2018.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; United States | 2023 |
Association between antimicrobial consumption and resistance rate of Escherichia coli in hospital settings.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Hospitals; Humans; Microbial Sensitivity Tests | 2023 |
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Frequency and Antibiotics Sensitivity Pattern of Culture-Positive Salmonella Typhi in Children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2023 |
Antimicrobial susceptibility pattern and genotypic characterisation of quinolone and ceftriaxone resistant genes among Salmonella typhi from various regions of Pakistan.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pakistan; Prospective Studies; Quinolones; Salmonella typhi; Typhoid Fever | 2022 |
Data-Driven Two-Stage Framework for Identification and Characterization of Different Antibiotic-Resistant Escherichia coli Isolates Based on Mass Spectrometry Data.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cefuroxime; Ciprofloxacin; Escherichia coli; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2023 |
Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Dysentery, Bacillary; Humans; Infant; Infant, Newborn; Mali; Microbial Sensitivity Tests; Shigella | 2023 |
Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities | 2023 |
Rapid Molecular Phenotypic Antimicrobial Susceptibility Test for
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Polymerase Chain Reaction | 2023 |
Epidemiology and antimicrobial resistance profile of Neisseria gonorrhoeae in Catalonia, Spain, 2016-2019.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Retrospective Studies; Spain | 2023 |
Sanguinarine, similar to the MICs of spectinomycin, exhibits good anti-Neisseria gonorrhoeae activity in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin | 2023 |
Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis.
Topics: Anti-Infective Agents; Australia; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillins; Retrospective Studies | 2023 |
From the Gut to the Heart: A Rare Case of Salmonella dublin Pericarditis.
Topics: Ceftriaxone; Ciprofloxacin; Humans; Male; Middle Aged; Pericardial Effusion; Pericarditis; Salmonella | 2023 |
Antimicrobial susceptibilities and genomic epidemiology of Neisseria gonorrhoeae in Stockholm, Sweden.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Genomics; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Sweden | 2023 |
Correlates of
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quebec; Sentinel Surveillance; Sexual and Gender Minorities | 2023 |
Genetic characterization of a Salmonella enterica serovar Typhimurium isolated from an infant with concurrent resistance to ceftriaxone, ciprofloxacin and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant; Multilocus Sequence Typing; Salmonella typhimurium; Serogroup | 2023 |
Australian Gonococcal Surveillance Programme Annual Report, 2022.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Population Surveillance; Rural Population | 2023 |
Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Molecular Typing; Mycobacterium tuberculosis; Neisseria gonorrhoeae; Penicillin G; South Africa; Tetracycline | 2023 |
Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of
Topics: Agar; Alberta; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Retrospective Studies; Tetracycline | 2023 |